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ABSTRACT 
The replication o·F the RNA genome of the rhabdovirus vesicular stoma-
titis virus (VSV) was studied in vivo and in vitro. The products of replication, 
(+) and (-) strand 42S RNA, were separated from the mRNA species in CsCI 
gradients, allowing the determination of the rates of 42S RNA synthesis through-
out the infecti ous cycle. It was found that 42S RNA synthesis and virus release 
occurred over a narrow timespan and were maximal at 5 hours (h) post-i nfecti on 
(PI). The ratio of (+): (-) strand 425 RNA shifted from 40: 60 at 2 h PI to 
20 : 80 at 4 h PI. Thi s shi ft was shown to be due to an increase in the ra te of 
(-) strand 425 R~~A synthesis while the rate of (+) strand 425 RNA synthesis 
remained constant. The apparent constance of the rate of (+) strand synthesis 
suggests that there are separate regulators of (+) and (-) strand synthesis. 
The replicative complex from V5V-infected HeLa cells was isolated in 
Renografin gradients. By pulse-labeling cells for 5 min at 5 h PI, we were 
able to isolate a complex which contained radiolabeled RNA molecules which 
ranged in size from 18S to 42S. Longer times of pulse-labeling demonstrated 
that the radi olabeled RNA sped es accumulated as 42S RNA. 
The characteristi cs of this complex were exami ned in several ways. We 
demonstrated that the nascent RNA species contained in the RNP ccmplexes 
were ribcnucl ease-resistant and si ngie-stranded, whi ch i ndi cates that the RNA 
species were associated with protein. The radiolabeled RNP complexes had an 
equilibrium density in CsCI identical to the virion nucleocapsid. Hybridization 
analyses of the nascent RNA species demonstrated that the ratio of (+): (-). RNA 
contained in the replicative complex was higher at 2 h PI than at 6 h PI/ just 
as we observed with the rates of synthesis of 425 RNA in vivo. The actual 
ratios of the RNA contained in the replicative complex and the 425 RNA iso-
lated in CsCI gradients were similar as well. The nascent (-) strand RNA which 
was approximately 185 in size was shown to be enriched for sequences identical 
to the 51 end of the genome RNA. These resLl1 ts strongly suggest that the RNP 
complexes we have isolated are in fact replicative complexes. 
The in vitro synthesis of genome-sized 425 RNA was observed using 
Iysates prepared from infected cells/ but not when virion RNPs were used in 
the reaction. The synthesis of several smaller unique RNA species was also 
observed in the crude cell extract system. The 425 RNA which was synthesized 
in vi tro was bound by an 01 igo(dT) col umn whi ch suggests that the 425 RNA 
contained poly(A). The synthesis of the 425 RNA was prevented when the cells 
were treated with cycloheximide prior to the preparation of the cell extract. 
The synthesis of full-length RNA was maximal at 5 h PI, the same time at which 
replication in vivo was shown to be maximal. Preliminary hybridization analy-
ses of the 425, 265 and 205 RNA species which were synthesized in vitro by the 
cell extracts indi cated that these RNA species were (+) strand in sense. 
vi 
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CHAPTER I 
INTRODUCTION 
Vesicular stomatitis virus (VSV), an enveloped animal virus which is the 
prototype vi rus of the rhabdovi rus group, has been used as a model system for 
the examination of various aspects of membrane biogenesis, viral pathogenesis, 
and viral RNA synthesis. The vesicular stomatitis subgroup includes VSV New 
Jersey and VSV Indiana, the two most commonly used serotypes in the labora-
tory (64). These viruses infect a wide variety of plant, vertebrate, and inver-
tebrate organisms. The group derives its name from the fact that rhabdoviruses 
appear rod-shaped when viewed in the electron mi croscope (Gr. rhabdos = rod). 
Structure of VSV 
The VSV vi ri on is made up of a (-) strand RNA genome and fi ve vrrus-
specific proteins. The virus can be separated into mo parts by treatment with 
nonionic detergents: an envelope containing the M and G proteins, and a 
nucleocapsid composed of the 42S RNA genome and the three remaining viral 
proteins (64). 
Envelope proteins 
The G, or glycoprotein, is a 67,000 dalton protein possessing two 
oligosaccharide chains linked to the protein (29). The G protein can be ob-
served in electron micrographs of negatively stained virions as a spike-like 
proiection extending radially from the surface of the virion envelope (15,39). 
The function of the G protein presumably is to aid in the adsorption of the 
virus to the host cell (15,16,17). 
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The M, or matrix r protein is the other virus-specific protein found 
associated with the virus envelope. It has a molecular weight of 28,000 and 
is likely situated either in the membrane or on the cytoplasmic side of the 
membrane (24,40,46). The exact function of the M protein is not known, but 
it has been proposed that the matrix protein provides a recognition site for the 
nucleocapsid at the site where virions bud from ,the cell surface and that it 
regulates the transcriptional activity of the virion nucleocapsid (14,17,18). 
Nucleocapsid proteins 
The nucleocapsid is made up of the N, NS, and L proteins in addition 
3 
to the 42S RNA genome. The L protei n (190,000 MW) and the NS protei n 
(45,000 MW) are present in approximately 60 copies of Land 230 copies of NS 
protein per nucleocapsid (64). These t\vo proteins form the viri on-associated 
RNA polymerase (RNA nucleotidyl transferase, EC 2.7.7.6) which can be acti-
vated in preparations of purified virions by the addition of low concentrations of 
nonionic detergents and nucleoside triphosphates (6,9,10). The Land NS pro-
teins can be dissociated from the nucleocapsid by the addition of high salt 
concentrations, leaving a ribonucleoprotein (RNP) core. The N protein (50,000 
MW) completely encloses the RNA genome, creating the helical RNP core 
which is the required template for transcription (10). The association of N pro-
tein to 425 RNA is specific and extremely stable; the N protein does not 
dissociate from the 42S RNA genome even when the RNA is being transcribed, 
and the RNA is protected from ribonuclease digestion when enclosed in the 
nuc I eocapsid (10,58). 
VSV RNA Synthesis 
Modes of repl i cati on and transcripti on 
of ss R NA vi ruses 
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The animal viruses which contain nonsegmented single-strand RNA 
genomes can be divided into two groups: the (+) strand viruses and the (-) 
strand viruses (5,54). The (+) strand viruses contain a genome identical to the 
viral mRNA and the genome RNA is therefore deemed to be of the (+) polarity. 
These viruses are perhaps best typified by poliovirus, a member of the picorna-
virus group. As outlined in Fig 1, the infecting poliovirus genome, itself 
infectious, acts as mRNA after entering the cell and produces a single poly-
protei n whi ch is processed into the vi ral protei ns (37). One or more of the 
viral proteins act as a viral replicase, able to recognize the (+) strand template 
and synthesize (-) strand antigenome RNA. The (-) strand serves as the tem-
plate for (+) strand synthesis. Progeny (+) strands can serve as both genome 
strands and mRNA, thus in the case of poliovirus, no distinction is made be-
tween repJ ication to produce full-length RNA and transcripti on to produce 
viral mRNA. 
VSV can be considered as an example of the (-) strand viruses which 
include the rhabdoviruses and the paramyxoviruses (64). The RNA genome of 
these viruses is complementary to the vi ral mRNA species, hence the polarity 
of the genome is (-). The 42S RNA genome must enter the cell as a nucl eo-
capsid in order to initiate the infection; free 425 RNA is not infectious (16,62). 
MODES OF REPLICATION AND TRANSCRIPTION 
OF ss RNA ANIMAL VIRUSES 
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As shown in Fig 1, the first step in the infectious cycle ofV5V is the transcrip-
tion of the genome by the virion-associated RNA-dependent RNA polymerase 
(transcriptase) to produce fi ve monoc istroni c messages. The VSV mRNAs are 
polyadenylated at the 3 1 end and are capped at the 51 end with the terminal 
modification [m7 G(5 1)ppp(51)xJ (55). The message species are translated and 
some of the transcriptase enzymes, either from the input nucleocapsid or newly 
translated from the mRNAs, are converted to replicase enzyme complexes by 
host and perhaps viral factors (64). This replicase is presumably able to produce 
full-length (+) strands from the (-) strand genome as well as produce progeny 
genome strands from the (+) strand templates. A~I of the 425 RNA synthesized 
is associated with N protein to form nucleocopsids (58). The (-) strand RNP 
complexes thus serve a dual role in VSV infections as the templates for the two 
separate processes of transcription and replication. 
Transcripti on of VSV 
The products of VSV transcription in vivo are five monocistronic mes-
sages representing the entire coding capacity or the genome (25,32,41,44,45, 
66). The virus will also transcribe in vitro since it carries the L protein-NS 
protein transcriptase as part of the virion nucleocapsid (6,9,10,26). The pro-
ducts of the in vitro reaction are identical to the in vivo messages in molecular 
weight, hybridization characteristics, polyadenylation, 51 terminal capping, 
and the ability to direct the synthesis of the viral proteins in vitro (2,4,8, 11, 
12,43,53). In addition to the five authentic mRNA species, there is a 48-
nucleotide-long lIleeder" RNA synthesized in vitro that is identical to the 5' 
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end of the (+) strand 425 RNA (19,20,21). The role of the leader is not known, 
although the portion of the genome coding for it should represent the binding 
and initiation site for the V5V transcriptase. It is also possible that the leader 
RNA is involved in the assembly of N protein to the (+) strand 425 RNA. 
Transcriptional activity of the virus can be destroyed by dissociating 
the Land NS proteins from the RNP core. Activity can be regained by adding 
the Land N5 protei ns back to puri fi ed cores (27,28). Us; ng su ch a reconsti tu-
tion system, Emerson and he r colleagues were able to demonstrate that the 
template for transcription was the RNP core consisting of the 425 RNA genome 
and the N protein (13,28) and that the transcriptase enzyme of VSV was com-
posed of both the Land N5 proteins (27,64). This report confirmed the earlier 
observations of Naito and Ishihama (47) who showed that the VSV New Jersey 
transcriptase was a dimer consisting of one molecule of L and one molecule of 
NS protein. 
The mechanism by which the transcriptase enzyme produces the message 
species is not known. Several investigators have provided evidence suggesting 
that the transcriptase binds to the 3 1 end of the genome and sequentially tran-
scribes the template in the order: (3')N-NS-M-G-L(5 1 ) (1,3,7). If one 
assumes that this hypothesis is correct, the observed results can be explained by 
two models of VSV transcription (Fig 2). The first model, called the processing 
model, predicts that the mRNA species are produced by the sequential read-
through of the five genes from a single promoter site, followed by endonucleo-
I yti c cI eavage of the transcript into message-si zed uni ts, capp i ng, poly-
adenylation, and methylation (3,7). The second model, called the stop-start 
MECHANrSMS OF TRANSCRIPTION 
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model, proposes that the transcriptase bi nds at the 3 1 end of the genome and 
sequentially transcribes the genes; however, the step-start model requires that 
each gene has j ts own promoter and termi nati on si tes for transcripti on. The 
stop-start model suggests that the transcriptase enzyme begi liS transcripti on at 
the leader RNA promoter site l transcribes the leader and terminates the trans-
cript at the end of the leader. The pol ymerase then moves on to the next 
promoter site (the N gene) and transcribes the gene in a similar fashion. The 
enti re genome is thus transcribed. 
It is difficult in practice to distinguish betlfveen a processing model and 
a stop-start model if in the processing model the message-sized RNA fragments 
are quickly cleaved from the read-through transcript. The processing model is 
favored by several researchers as a resul t of the observati on that the triphos-
phate "bridge" of the 51 terminal cap of the V5V mRNAs (m7 GpppX) derives 
only one phosphate group from the nucleotide adjacent to the inverted G 
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residue (X) whereas most other eukaryotic mRNAs have a cap whose triphos-
phate group derives two of the three phosphates from the X nucleotide (3 /71 55). 
This may mean that prior to the addition of the capi the penultimate residue 
was pX and not pppX, indi catj ng that the message may have origi nated from 
the cleavage of a longer transcript. 
Replication of V5V 
Replication ofV5V is the process whereby 425 RNA of both (+) and 
(-) polarities are produced. Although the virion contains only (-) strand 42S 
RNA in the nucleocapsid, intracellular nucleocapsids contain both polarities 
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of 42S RNA (58). The role of the (+) strand presumably is to act as the template 
for progeny (-) strand synthesis. 
It has been assumed that the active template for replication is a ribo-
nucleoprotein complex simi lar to the transcriptive template be~ause the tran-
scriptive template was shown to be an RNP complex (13/27) and because the 
(+) strand template is always fou;,d coated 'Nith N protein as an intrace!lular 
nucleocapsid with the same equilibrium density in CsCI as the virion nucleo-
capsid (58). In addition/ studies using temperature-sensitive mutants of VSV 
have shown that transcription .:lnd ieplication may be interde?e!1dent processes 
(22/23,38,50,51/52). Pedman and H1Jong (50) demonstrated that cells infected 
with the complementatio~ group I muta~f tsG 114 produced only 425 RN.t\ at 
the ;'estrictive temperature, bu.t. upon th~ addition of cycloheximide, replication 
ceased and transcripti on began. The defect in tsG 114 was subseque!1tl y shovvn 
to be in the L protein, suggesting that the L protein is involved in both 
rep Ii cati on and transcripti on (3.3/3-4). 
However/ replication differs from transcription in that the products of 
replication are (+) and (-) strands of full-length RNA coated with N protein 
whereas the products of transcripti on are the (+) strand monocistroni c messages. 
The mRNAs can comple~ with N protein to form a messenger RNP comp lex/ but 
the mRNPs are not stable in 3M CsCI and the mRNA contained in mRNPs is 
ribonuclease-sensitive unlike the 425 RNA containing nucleocapsids which 
band in CsCI and are ribonuclease-resistant (31,58). It is also likely that 
replication requires continuous protein synthesis because the addition of the 
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translational inhibitor cycloheximide to VSV-infected cells prevents the synthe-
sis of full-length RNA without affecting the production of the message species 
(65) . 
Evidence also suggests that there are host factors required for VSV 
replication but not for transcription. Growth restriction of wild-type strains 
of VSV has been observed with human Iymphob lasts and rabbit corneal cells 
and a block in the replication of the 425 RNA was noted (48,63). The nature 
of the host factor(s) is not known, although "host-range ll mutants of VSV have 
been isolated which can replicate in certain cell lines but not in others, 
demonstrating that host factors may interact with VSV proteins (42,49,56,57, 
59). One of the host-range mutants was shown to contai n a thermolabi Ie L 
protein (60,61). This indicates that the host factor may complex with the L 
protein and convert the transcriptase to a replicase. The host factor is not 
inactivated by pretreating cells with Actinomycin Di therefore either the factor 
or its message is stable (36). 
The possible involvement of a host factor with the VSV replicase is not 
wi thout precedence. The (+) strand RNA bacteri ophage Qil possesses a repl i-
case composed of a virus-specific polypeptide and several host polypeptides 
(35). In addition, another host-specific protein, designated host-foctor I, is 
requi red for the produc ti on of the Q(3 (-) strand anti genome, but is not necessary 
for the synthesis of the (+) strand genome (30). The example provi ded by the 
QI1 system may not be applicable to VSV replication since the templates and 
products of VSV replication are ribonucleoprotein complexes and not free RNA 
as is the case for Q(3. 
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Possible mechanisms of YSY replication 
Models of YSY replication can be derived from the transcriptive models 
shown in Fig 2 by modifying certain aspects of the processing and stop-start 
models. In the processing modei, replicati on could occur when the processing 
enzymes are somehow prevented from cleaving the read-through transcript into 
the gene-sized uni ts. The stop-start model can be converted to a rep I i cati on-
transcription model by proposing that the transcriptase enzyme is converted to 
a replicase enzyme which can no longer recognize the termination signals at 
the end of each gene, thus producing a 42S RNA molecule instead of the mes-
sages. There are two additional aspects of replication that should be con-
sidered. The first is that the N protein must specifically associate with full-
length (+) and (-) R!'\IA to form the ribonuclease-resistant nucleocapsids. The 
second aspect to be considered is that only full-length (-) strand RNA is 
synthesized; the mechanism which discriminates between replication to form 
(+) strand 425 RNA and transcription to produce the mRNA species is not 
appl icable to synthesis of the (-) strand. 
Research Plan 
In order to better understand how the (-) strand RNA viruses regulate 
their RNA synthesis, we have chosen to study the replicati on of YSV. The 
major goal of these studies presented herein is the eventual understanding of 
the means by which YSY replicates its RNA, packages that RNA into a nucleo-
capsid, and releases (-) strand nucleocapsids from the cell. The immediate 
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goal is the establishment of an in vitro replication system which will allow the 
enzymology of VSV replication to be examined. To achieve this, we have 
characterized the kinetics of in vivo replication, isolated and examined the 
rep/ i cati ve intermediate of VSV, and exami ned the RNA spec i es which are 
produced in vitro by VSV-infected HeLa cell extracts. The results of these 
studies are presented in the following sections. 
14 
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CHAPTER II 
RNA SYNTHESIS IN VESICULAR STOMATITIS VIRUS-INFECTED 
CELLS: IN VIVO REGULATION OF REPLICATION 
by 
Christian C. Simonsen r Sue Batt-Humphries 
and Donald F. Summers 
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Introducti on 
Vesicular stomatitis virus (V5V), a member of the rhabdovirus group, 
contains a simgle RNA strand of molecular weight 3.6 - 4.0 x 106 • This RNA 
has been shown to serve as the template from which the five virus-specific 
mRNA species are transcribed (35). These mRNAs code for '~he five known viral 
proteins: G, the viral envelope glycoprotein; MI the matrix protein; Land N5, 
the components of the virion-ossociated polymerase; and N, the protein which 
together with the virion polymerase and RNA compd:ses the nucleocapsid portion 
of the virion (35). The virion RNA-dependent RNA polymerase has been shown 
to be capable of synthesizing RNA in vitro (4,6). Recent work has demonstrated 
that the RNA synthesized in vitro is one of the same sizes as that found in vivo 
and, like the in vivo mRNAs, the in vitro RNAs are polyadenylated, capped 
and methylated, and are complementary to the virion 425 RNA (1,5,22,29). 
Although only (-) strands are released in mature virions, full-length (+) 
and (-) strands are found in the infected cell as ribonucleoprotein complexes 
which are made up of primarily N protein and 425 RNA (32). The (-) strand 
RNPs serve three functional roles. They are the RNPs which are ultimately 
packaged in the virion, rhe templates for transcription, and the templates from 
whi ch the full-length (+) 425 RNA is synthesized. AI though larger than gene 
size mRNAs have been reported (13), the (+) 425 RNA likely arises from a sepa-
rate mechanism since its synthesis is cycloheximide sensitive whereas transcrip-
Hve products are not (37). The RNPs containing (+) 425 RNA are the templates 
from which the (-) 425 RNA molecules are synthesized. The five V5V-specific 
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mRNAs are also found as ribonucleoproteins; however I these mRNPs are different 
from the RNPs containing 425 since RNPs containing 425 RNA are ribonuclease-
resistant and stable in 3M CsCI whereas the mRNPs are sensitive to ribonuclease 
and are not stable in CsCI unless fixed with gluteraldehyde (11,32). 
Temperature-sensitive mutants conditionally defective in the L protein, 
such as tsG 114, have demonstrated a relati onship between repl icati on and trans-
cription (26,27,33). Cells infected with the mutant tsG114 will replicate 425 
RNA at the restrictive temperature but will not produce mRNAi upon the addition 
of cycloheximide, replication is inhibited and transcription is recovered. These 
resul ts and others suggest that the L protein is part of both the repl icative and 
transcriptive enzymes (8,15,24). 
In order to more fully understand the ieplicative process, a variety of 
biochemical and genetic studies have been performed by many investigators (14, 
18,26,37). Previous studies showed that approximately 20% of the genome-
length RNA synthesized at 4 h post-infection is complementary to the virion 
strand (32). 5chincariol and Howatson (30) and Wertz (36) have suggested a 
possible role in replication of duplex molecules. The role of these duplex mole-
cules in replicative intermediates is unclear since full-length VSV RNA is found 
predominantly in RNP complexes in the cell (32). 
In the present report, we have examined the synthesis of full-length 
VSV RNA of both polarities in order to better understand the replicative process. 
Our results confirm and extend earlier studies on the synthesis of VSV-specific 
RNA species (27) by differentiating (+) 42S RNA from the VSV mRNAs which 
are also (+) stranded. 
Materials and Methods 
Cells, virus infection, and radioactive 
labeling 
23 
Suspension cultures of HeLa S3 cells or BHK cells were grown in Joklik's 
modified minimal essential medium (Flow Laboratories), supplemented with 2 mM 
glutamine plus 5% fetal calf serum (Flow Laboratories) at a concentration of 
5 6 x 10 cells per mi. Stock preparation of VSV (Indiana serotype) were grown 
in HeLa cells, purified, and assayed as described previously (12,23). Cells were 
collected by centrifugation, resuspended in growth medium minus serum at a 
concentration of 6 x 106 cells per ml, and were then infected with 10 PFU of 
VSV per cell. At 1 h post-infection, serum was added to 5~{' and actinomycin 
D (a gift from Merck, Sharpe and Dohme) was added to 1 }lg per mi. At times 
ranging from 1.5 h to 10 h post-infection, infected cells were incubated in the 
presence of 50 to 100 }lCi per ml of l3 H]-uridine (25-30 Ci/mmol, New England 
Nuclear) . 
Isolation of VSV nucleocapsids and 
nuel eocapsi d 425 RNA 
Cells (5 to 10 ml samples) were removed from infected cultures at desig-
nated intervals, centrifuged for 3 min at 900 x g at4° C, and resuspended in 
1 mJ of NT buffer (0. 1 M NaCl, 0.01 M Tris, pH 7.5) and O. 1 ml l001a NP40 
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(11). The cells were left on ice for 15 min and the nuclei were removed by cen-
trifugation for 3 min at 900 x g. The nuclei were then washed in 1 ml of 0.2% 
deoxycholate, 0.3% NP40 in NT buffer and recentrifuged. The supernatants 
from the 19b NP40 treatment and the deoxycholate-NP40 wash were combined 
and layered onto a preformed 8-ml 20-40<:>10 (w/v) CsCI gradient with a 2-ml 
overlay of 5% sucrose in TNE buffer (25 mM Tris-HCI, pH 7.5, 50 mM NoCI, 
and 2 mM EDT A), and centrifuged for 16 h at 33,000 rpm at 4 0 ( in the Spinco 
SW 41 rotor as previously described (19). The nucleocapsid band, which was 
present in the middle of the (sCI portion of the gradient, was removed from the 
side of the tube with a syringe and diluted to 1 ml with NETS buffer (0.1 M 
NoCI, 0.01 M Tris, pH 7.5, 1 mM EDTAr 0.2% SDS). Aliquots of 0.05 ml 
were precipi tated by the additi on of tri chloroacetic acid and quanti tated as 
previously described (2,3). 
Hybridization of VSV RNA 
Hybridizations were performed in sealed capillary pipettes in 0.02 ml 
using the conditions of Kolakofsky (19,20). To each aliquot of 3H- RNA isolated 
from nucleocapsids was added increasing amounts of unlabeled VSV 42S RNA or 
mRNA. The samples were then heat-denatured by heating to 100° C for 3 min 
and incubated 3 hat 73° C. Each sample was treated with a 30tJg/mI solution 
of Ribonuclease A ~Northington) for 30 min at 250 ( and was then assayed for 
acid precipitable radioactivity as described above. The self-annealing 
reactions were identi cal except that no unlabeled RNA was added to the samples. 
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Purification of VSV-specific RNA 
Minus-strand 42S RNA was prepared from purified virions by disrupting 
the virus in NETS buffer and centrifuging the samples on 15-50% sucrose-SOS 
gradients as described above. The 425 RNA was ethanol precipi tated and dis-
solved in 2 x A buffer (0.3 M NaCl, 0.02 M Tris, pH 7.4,0.002 M EOTA). 
VSV mRNA was prepared from infected cells at 4.5 h post-infection. A cyto-
plasmic extract was prepared as described above and was phenol-extracted using 
an SDS-hot phenol technique as follows. The extract was mixed with an equal 
volume of NETS buffer-saturated phenol and heated 3 min at 650 C. The phases 
were separated by centrifugi ng at 900 x g for 3 mi n. The phenol phase was re-
extracted with NETS and the aqueous phases from both extracti ons were com-
bi ned and ethanol precipitated. Polyadenylated RNA was puri fi ed on an 01 igo 
(dT)col umn according to Banerjee and Rhodes (5). The mRNA was ethanol 
precipi tated and di ssol ved in 2 x A buffer at a concentrati on of 250 !-1 g/ml • 
Iodination of nucleocapsid RNA 
A modification by P. R. Shank of the standard methods was used (28). 
Nucleocapsids were isolated from infected cells at 2,4, and 6 h post-infection. 
The RNA was phenol-extracted, ethanol precipitated and lyophilized. 0.0. 
260/280 was greater than 2 on a II sampl es. l1-'g sampl es were di ssol ved in 
30 j-ll 0.1 M NaAc, pH 4.5. 1 mCi of corrier-free Na 125 (New England 
Nuclear, greater than 300 mCi/ml, pH 8-10) was added followed by the addi-
tion of 0.005 M thallium trichloride solution to a final concentration of 
6.25 x 10-4 M. (The thai I ium tri chi oride was made up as a O. 1 M stock 
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solution in 1 N HCI. It was diluted to 0.055 M by the addition of 0.1 M NaAc, 
pH 4.5 immediately prior to use.) The RNA solution was tightly stoppered and 
incubated at 600 C for 12 min. The sample was chilled on ice and 150 ~I of 
0.5 M phosphate buffer, pH 7.3, was added. This was incubated at 600 C for 
30 min. The 1251_ RNA was then purified by Sephadex G-50 filtration, fol-
lowed by banding in (sTCA gradients according to the method of Burke and 
Bauer (7). The RNA was ethanol precipitated and used for hybridizations as 
previously described. 
Rate of uridine incorporation in VSV 
infected cells 
Results 
Although the kinetics of RNA synthesis in vitro have been extensively 
studied (4,6,33), the kinetics of in vivo RNA synthesis are not as well described. 
To determine the rates of synthesis of VSV-specific mRNA and 425 RNA, aliquots 
of a culture of infected HeLa cells were removed at one-hour intervals through-
out the infection and were radiolabeled by the addition of [3Hl-uridine for 30 
min. Samples from each aliquot were analyzed for total uridine incorporation, 
and the remainder of each sample was centrifuged in 20-40% CsCI gradients in 
order to separate nucleocapsids from the messages. An opalescent band could 
be seen in the middle of the gradient after centrifugation at a density of 1.31 
glcc, the reported density for V5V nucleocapsids (11). Acid precipitable radio-
activity in the gradients was found only in the nucleocapsid band and in a pellet 
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at the bottom of the geadient (data not shown). The labeled material was then 
analyzed in 15-30% sucrose-SDS gradients. 
As Fig. 1 demonstrates, the CsCI gradients fractionated the infected cell 
RNA into two distinct populations; VSV mRNA was found only in the pellet of 
the CsCI gradients (panel A) and 425 RNA was found only in the 1.31 glcc 
band in the middle of the gradient (panel B). This is in agreement with previous 
reports which have shown that VSV mRNPs are not stable in CsCI (11). RNA 
which is not associated with protein in CsCI wiH pellet. 
This technique allowed us to directly determine the rate of replication 
of the 425 RNA as well as to compare the rate of replication to the rate of 
transcription. This result is shown in Fig. 2. Incorpaation of uridine was bi-
phasic, with peaks of incorporation occurring at 3.5 and 6.5 h post.-infection. 
The maximal rate of replication did not coincide with the two transcription 
peaks, rather it peaked at 4.5 h post-infection. 
Uridine transport in VSV infected cells 
The biphasic uridine incorporation into mRNA species that we observed 
couJd be due to a change in the rates of RNA synthesis or a change in the intra-
cellular levels of uridine throughout the infection. Transport of uridine into 
chick embryo cells infected with V5V decreases logarithmically after infection, 
although HeLa cell uridine transport is not affected to the same degree (10). 
Since it is likely that only one pooJ of pyrimidine nucleotides serves the synthesis 
of virus-infected HeLa cells (31), we examined whether Auctuations in the intra-
cellular pool of (3 H]-uridine couid account fer the result shown in Fig. 2. 
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Fig. 1. Velocity sedimentation analysis of RNA isolated from VSV-infected 
cells and fractionated on CsCI gradients. Infected HeLa cells were incubated 
for 30 min in the presence of 50 ~Ci/ml [3H]-uridine at 4.5 h post-infection. A 
cell lysate was made from these cells and was centrifuged in a 20-4Q<1o CsCI 
gradient. We recovered 73% of the inpul' radioactivity in the cytoplasm from 
these gradients as nucleocapsid RNA (16';f,) and as mRNA in the pellet (570/0). 
No peak of radioactivity was otherwise present. The nucleocapsids were dis-
solved in NETS buffer, and the RNA in the pellet was dissolved in NET buffer 
which was 1% Sarkosyl. These samples were layered onto 15-30010 5ucrose-SDS 
gradients with 14C-uridine labeled marker RNAs. The gradients were centri-
fuged for 16 h at 20,000 rpm at 200 C in the SW-41 rotor. The gradients were 
dripped from the bottom of the tube into O.5-ml fractions and acid-precipitable 
radioactivity was determined for each fraction. The locations of the marker 
RNAs are indicated by the arrows in panel A. Conditions of infecHon, label-
i ng I preparoti on of the cell extract, CsC I gradient centri fugati on I ard deter-
mination of acid-precipitable radioactivity are as described in the Materials and 
Methods; A) RNA from CsCI pellet; B) RNA isolated from nucleocapsid band. 
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Fig. 2. Rate of RNA synthesis in VSV-infected HeLa cells. Ten-ml aliquots 
in infected cells were withdrawn at the times indicated and incubated in the 
presence of 50 ~Ci/ml [3 H]-uridine for 30 min. Duplicate 100tJI samples 
were TCA precipitated! and the remainder of the aliquot was lysed in O. l~{;, 
NP40. The cytoplasmi c extracts were layered onto 20-40% CsCI gradients 
and were centrifuged in the SW-41 rotor, 16 h, 33!000 rpm, at 40 C. The 
nucleocapsid band was collected and dissolved in NETS buffer. Conditions of 
infection, cell lysis, CsCI gradients, and quantitation of the RNA in the 
nucleocapsids and the pellet are as described in the Materials and Methods • 



















Aliquots of infected cells were removed at hourly intervals and were 
incubated in the presence of [3Hl-uridine. After allowing the cell pools to 
32 
equilibrate for 15 min in the presence of the radiolabel, the cells were washed 
with fresh, ice-cold media and lysed with distilled H20. An equal volume of 
10010 TCAwas added and the samples were filtered. Aliquots from the acid-
soluble material were directly counted and acid-precipitable material on the 
filters was also quantitated. The results are shown in Fig. 3. The initial peak 
of uridine incorporation is due primarily to a transient increase in the intra-
cellular levels of [3 H]-uridine. The intracellular pool of label decreases after-
wards and does not account for the maximal rate of replication which does not 
coincide with either of the biphasic peaks of incorporation. We have observed 
this result with [14C]-uridine as well. 
A biphasic amino acid incorporation rate curve has been observed in 
VSV-infected HeLa cells (Mudd, J. A., Ph.D. thesis, Yeshiva University, 
1971). Our resul ts are perhaps due to a general membrane phenomenon in VSV-
infected cells. Our results support the idea that the cell becomes transiently 
more permeable to uridine pri or to the time nucleocapsid assembly becomes 
maximal. Although the first peak of mRNA synthesis does not reflect a true 
increase in the rate of RNA synthesis, the second peak of RNA synthesis does. 
Even if the rate of uridine incorporation into message and genome length RNA 
is corrected for the changes in the intracellular levels of uridine, it is clear that 
the true maximal rate of transcripti on occurs at a different time than that of 
repl icati on. 
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Fig. 3. Acid-soluble radioactivity versus acid-precipitable radioactivity in 
VSV-infected cells. Cells were infected as described in Materials and Methods. 
Aliquots were removed at hourly intervals throughout the infection and were 
incubated in the presence of [3 H]-uridine for 15 min. Duplicate O.2-ml samples 
were lysed in 1 ml H20 followed by 1 ml 10% TCA. The samples were then fil-
tered through GFB filters and washed tvvice with 0.5 ml S% TCA. The radio-
acti vi ty present in the wash through fracti ons and on the fi I ters was qlJanti tated 
by counting in a Beckman scinti!1ation counter. ( ... --.), acid-precipitable 
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Intracellular 425 RNA synthesized early 
and late in the infection 
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We wi shed to detenni ne whether or not the ratio of (-) : (+) 425 RNA was 
constant throughout the infectious cycle. Late in the infection, 800/0 of the 
425 RNA synthesized is minus strand (32). This is expected since only the minus 
strand is packaged into mature virions (35). To determine the ratios of newly 
synthesized (+) and (-) 425 RNA, nucleocapsids were isolated from cells which 
were pulse-labeled for 30 min with [3Hl-uridine at 2,4, or 6 h post-infection. 
The 425 RNA from the nucleocapsids was purified on 5D5-sucrose gradients and 
hybridized with an excess of unlabeled V5V mRNA and genome 425 RNA. The 
percentage of ribonuclease-resistant labeled 425 RNA remaining after hybridi-
zation with either the unlabeled mRNA or genome 425 is shown in Table 1. Our 
resul ts for the 4 and 6 h time points agree wi th other reports (32); however, 
early in the infection (2 h) the percentage of (+) 425 RNA is significantly 
greater. 
If this is true, then the percentage of intracellular 425 RNA which can 
sel f anneal to form a double-strand RNA molecule composed of two 425 RNA 
molecules should also be higher at 2 h post-infection. To test this hypothesis, 
viral RNA was pulse-labeled with r3Hl-uridine in vivo, intracellular nucleo-
capsids were isolated at 2, 4, and 6 h Pit and the RNA contained in the 
nucleocapsids extracted. Intracellular nucleocapsids were also isolated at 2, 
4, and 6 h PI from infected cells which were not radiolabeled. The RNA from 
these nucleocapsids was extracted, and the RNA was radiolabeled in vitro with 
(1251] . 
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Table 1. Hybridization of pulse-labeled 425 RNA with unlabeled V5V-specific 
RNA. 
Hour Total Unlabeled RNA added to annealing reactions post-
mRNA 425 RNA infecti on cpm 
cpm 0/0 cpm ~'a 
"a 1086 625 58 403 37 .... 
2b 4668 2775 60 1641 35 
4
a 
1640 1233 75 412 25 
6a 807 685 85 172 21 
,b 
1355 1073 79 425 31 0 
V5V mRNA 2902 101 3 2890 99 
425 RNA 1582 1459 92 
Nucleocapsids were isolated from V5V-infected cells at 2, 4, and 6 h PI after 
being pulse-labeled for 30 min with [3H]-uridine as described in the Materials 
and Methods. The purified RNA was annealed with increasing amounts of un-
labeled V5V mRNA or 425 RN.A, in 2D,l1 reaction volumes using the method of 
Kolakofsky (19,20). Plateau levels of ribonuclease-resistant material present 
after a 3 h incubation at 73
0 
C are expressed in the table after being corrected 
for the ribonucl ease-resi stant material present before the i ncubati on. This 
figure varied from 4<Jo to 8% of the input radioactivity. 
°RN.A. from V5V-infected Hela cells. 
bRNA from VSV-infected BHK cells. 
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The [1251]_RN~A. provided us with labeled 425 RNA which represented 
all of the 425 RNA which was present in the cell at the time of isolation. The 
[3 H]-labeled samples contcined (+) and (-) 425 RNA that was both labeled and 
unlabeled since it contained 425 RNA present in the cell prior to the addition 
. 3 125 
of the radlolabel. These [ H]- and [ I)-RNA samples were self annealed to 
determine the [3 HJ (pulse-label) and [1251] (total RNA) which is ribonuclease-
resistant. As Table 2 demonstrates, the amount of self annealing was higher in 
both the [3H] and [1251] samples isolated at 2 h PI than the samples which were 
isolated at 4 and 6 h post-infection. This shows that the shift in the (+) : (-) 
ratio which we observed in Table 1 was not due to fluctuations in the levels of 
intracellular uridine shown in Fig. 3. The fraction of the samples which was 
ribonuclease-resistant in the 4 and 6 h pulse-labeled samples was identi cal to 
the fraction of the 4 and 6 h pulse-labeled samples which was ribonuclease-
resistant after being hybridized in the presence of added unlabeled genome 
strand 425 RNA, indicating that the unlabeled RNA which was present in the 
later samples was predomi nantl y (-) strand. 
The separation of 425 RNA from the mRNAs in the (sCI gradients 
allowed us to estimate the number of 425 RNA molecules of both polarities pre-
sent in the cell at 2, 4, and 6 h PI by isolating the nucleocapsids and quanti-
tatj ng the amount of RNA contai ned in the nucl eocapsi as. The re~ati ve amounts 
of 425 RNA present in the cell can also be estimated by comparing the rates of 
replication at 2, 4, and 6 h PI shown in Fig. 2. The comparison is shown in 
Table 3. The observed 2:4:6 ratio and the predicted ratio are in close 
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Table 2. Self annealing of RNA isolated from nucleocapsids. 





i nfecti on total annealed % total annealed 910 
2a 1086 493 45 4,050 3, 150 78 
4a 1640 419 26 29,900 13,184 44 
6a 807 203 25 21,787 8,309 38 
2b 4668 1894 41 
6b 1355 348 26 
Pulse-labeled [3 H]-RNA from Table 1 or [1251]_RNA (approximate specific 
activity 600,000 cpm!\lg) was heated to 1150 C for 1 min and plunged into an 
ice bath. The samples (10-20 ng in 20 ..,1 volumes) were incubated at 73° C for 
3 h (for the pulse-labeled RNA) or for 24 h (for the 1251_RNA). Ribonuclease 
resistance was determined as described in the Materials and Methods. The data 
are corrected for ribonuclease-resistant core structures as for Table 1. 
a RNA isolated from VSV-infected HeLa cells. 
bRNA isolated from VSV-infected BHK cells. 
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Table 3. Quantitation of intracellular 425 RNA. 
Hours 425 RNA 2 : 4 : 6 h ra t i 0 
post- A260 3 
molecules! pg!10 
a b i nfecti on A280 cells cell observed predicted 
2 2.2 2 300 1 
4 2.0 10 1600 5.3 5 
6 1 .9 25 3900 13 9 
Nucleocapsids were isolated from infected cells at 2, 4, and 6 h post-infection. 
The RNA was purified as in Table 1, and the absorbance was determined. The 
cal culati ons were made assumi ng a molecular weight of 3.6 x 106 for V5V 425 
RNA and an extinction coefficient at 260 nm of 25 per ng. 
cgreement, even though we did not correct the predicted ratio for nonuniform 
labeling due to the changes in the intracellular levels of [3H]-uridine which 
occur during the infection (Fig. 3). 
Release of mature virions throughout the 
infection 
The release of infectious VSV has been examined by plaque assaying 
aliquots from an i nfec ted cell supernatant throughout the i nfecti on (35). This 
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process has been characterized as a progressive release of viri ons throughout the 
infectious cycle. Fig. 2, however, demonstrates that the production of nucleo-
capsids is not progressive; rather it occurs in a relatively short time. Pulse-chase 
studies have shown that the incorporation of the L, N, and NS proteins begins 
to occur within 20 min after synthesis (16). Newly synthesized 42S RNA is . 
found associated with these proteins as a nucleocapsid-like ribonucleoprotein 
complex within 5 min of its synthesis (Hill, Simonsen, and Summers, submitted 
for publication). We therefore decided to assay rhe release of radiorabeled virus 
to determine if virion release coincided with 42S RNA synthesis, or if the 
nucleocapsids were slowly and continually released from the cell as mature 
virions. The former case would be a possible explanation for the sharp decrease 
in uridine transport which we have observed coinciding with maximal replication 
since it impties that substantial changes in the membranes could occur at the 
same time. 
Cells from a culture similar to that described in Fig. 1 were infected 
with 10 pfu VSV per cell. At 1 h post-infection, the cells were diluted ten-
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fold in order to minimize viral readsorption as the infection proceeded (Mudd, 
J. A., Ph.D. thesis, Yeshiva University, 1971). At 1-h intervals, 10-ml 
aliquots were removed and were incubated in the presence of [3H]-uridine for 
1 h. The cells were removed by centrifugation and the supernatants were 
layered onto 25-m[ 10-50010 sucrose gradients. After centrifuging, the gradients 
were collected by pumpi ng out from the bottom. A visible virus band could be 
observed in the lower portion of the gradients from all but the earliest time 
points. The amounts of acid-precipitable radioactivity that co-purified with 
the virus was determined for each sample (Fig. 4). The release of VSV from 
HeLa cells increases until 5 h PI and then decreases rapidly; similar results were 
obtained wi th a suspensi on cui ture of BH K-21 cells (data not shown). A plaque 
assay of the samples was performed, which also indi cated that the maximal rate 
of virus release occurred at Or near 5 h post-infection (data not shown). Fig. 5 
demonstrates that a continuously labeled culture of BHK-21 cells infected with 
VSV does not release appreciable amounts of virus until 4 h post-infection and 
that the release of virus is nearly complete by 7 h post-infection. Uridine in-
corporation plateaus at about 5 h post-infection in BHK-21 cells; thus the 
absence of radi olabeled virus late in the infecti on is due to both a decrease in 
labeling and to a decrease in the number of particles released since a plaque 
assay of the same samples showed that the number of infecti ous parti cI es also 
plateaued at 8 h post-infecti on (data not shown). 
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Fig. 4. Rate of VSV release in HeLa cells. Ten-ml samples of VSV-infected 
HeLa cells at a density of 5 x 105 cells/ml were incubated at the time indicated 
in the presence of 50 I-lCi/ml [3 H]-uridine for 1 h. The cells were removed by 
centrifugation and washed in 1 mi fresh media at 4 0 C. The supernatants were 
combined and layered onto 25-ml 10-50% sucrose-ET gradients (10 mM Tris, 
pH 7.5/ 1 mM EDTA) which were centrifuged for 16 h at 23/000 rpm at 4 0 C 
in the SvV-27 rotor. The gradients were pumped out and the fracti ons assayed 
for acid-precipitable radioactivity. The radioactivity banded with the visible 
opalescent virus band. Conditions of infection and assay of radioactivity are 
as described in Materials and Methods. 
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20 
2 4 6 8 10 
Time of Addition of [3H]-Uridine (h) 
Fig. 5. Continuous label of VSV-infected BH K cells. I nfection of BH K-21 
cells was performed as described in the Methods and Materials. 50 jJCi/ml 
[3Hl-uridine was added to the culture at 2 h post-infection. Duplicate 
1 OO~I samples were removed from the culture at hourly intervals and the 
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released virus was assayed as for Fig. 4. ( •• --•• )/ total uridine incoporation; 
(0-----0)/ virus release; (100% = 32/000 cprn). 
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In this paper we have demonstrated that the rate of uridine incorporation 
into acid-precipitable material in V5V-infected HeLa cells is biphasic (Fig. 2). 
This is due primarily to fluctuations in the intracellular levels of uridine (Fig. 
3). The synthesis of 425 RNA is maximal at 5 h PI, which does not coincide 
with either of the times at which uridine incorporation peaks. The ratio of 
(-) : (+) 425 RNA synthesis is not constant throughout the infection (Table 1). 
Early in the i nfecti on 40% of the 425 strands synthesi zed are comp lementary to 
the genome. Later in the infection, (+) strands comprise only 200/0 of the 425 
strands which are produced. Virus release closely parallels the replication of 
the 425 RNA (Fig. 4). 
Previ ous resul ts with a V5V temperature-sensitive mutant in RNA syn-
thesis, tsG 114, have indicated that transcription and replication are somehow 
interrelated (26,27). We set out to study the relative rates of synthesis of the 
genome-length 425 RNA and of the V5V mRNAs in order to better define the 
V5V repfi catj on process. Furthermore, we wished to determine if the synthesis 
of (+) 425 RNA was linked to the synthesis of the (-) strand since the only 
apparent functi on of the (+) strand is to serve as the template for the synthesis 
of the 425 minus strand. The use of (sCI gradients to separate the products of 
transcription from those of replication allowed us to easily separate 425 RNA 
from the V5V mRNAs. Even though an increase in the intracellular levels of 
uridine causes an apparent biphasic rate of uridine incorporation during the 
infection, Fig. 2 demonstrates that the maximal rates of replication and 
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transcription do not coincide. This suggests that the control of replication and 
transcription may be separate. It is possible that the pool of uridine which is 
utilized for replication of the 425 RNA is distinct from that which is used for 
transcription; however, there appears to be only one cytoplasmic pool of pyrim-
idine nucleotides (29). Furthem10re, the replication of V5V is possible in 
enucleated cells which indicates that a nuclear uridine pool is not required for 
the rep Ii catj on process (9). 
Our resul ts a I SO i ndi cote that the regula ti on of (+) 425 RNA synthes is 
may not be coupled to (-) strand synthesis. We isolated nucleocapsids at several 
different times in the infection and hybridized the 425 RNA in order to deter-
mine the ratio of (-) : (+) 425 RNA synthesized at the times tested. Early in the 
infection, nearly equivalent amounts of (+) and (-) strands are synthesized, 
whereas late in the infection 80% of the full-length RNA is minus strand. A 
competiti on effect whereby the putative replicase enzyme competes with the 
transcriptase enzyme for a recognition site at or near the 3' end of the (-) strand 
RNP can explain this result. However, Tables 1 and 2 are in close agreement, 
showing that 40010 of the 425 RNA molecules synthesized at 2 h PI are plus 
strand. I f the number of (+) 425 strands present per cell is cal culated for each 
of the time points by multiplying the number of 425 molecules per cell (Table 3) 
by the fracti on of (+) strands present at that time (1/2 of the fracti on of sel f 
annealed [125 11 _RNA , Table 2), it can be seen that the increase of (+) strands 
from 2 to 6 h is linear. This suggests that the (+) strand RNPs are stable through-
out the infection and that the number of (-) strand RNP complexes which are 
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able to replicate is constant. A similar observation for poliovirus replication 
has been reported (21). In the case of poliovirus, viral polymerase activity is 
porportionaJ to the levels of a viral polypeptide synthesized early in infecti on. 
Late synthesis of viral polymerase appears to produce non-functional molecules. 
We are presently studying RNP complexes synthesized late in the infection in 
order to determine if this is indeed the reason for the shift in the (-): (+) 425 
RNA ratio. 
We have also shown that the rate of viral release (Fig. 4) closely follows 
the rate of 425 RNA synthesis (Fig. 2). We were surprised to observe that both 
425 replication and viral release were maximal prior to the time at which mRNA 
synthesis was maximal. This apparent lack of interdependence of replication 
and transcription is not understood. It is interesting to note, however, that 
defective-interfering particles are released over a relatively short period of 
time which is much Jater than the period in which normal virus particles are 
released (17, and S. Moyer, personal communication). 
The regulation of V5V rep Ii cati on remai ns poorly defined. The temporal 
relati onship of transcripti on and repl i cati on suggest that separate regulatory 
mechanisms exist. A different type of regulation was suggested by the increase 
in the (-) : (-:-) ratio of 42S RNA molecules as the infection proceeded. We have 
used the temporal dependence of replication in order to establish an in vitro 
VSV replication system (Batt-Humphries, Simonsen, and Ehrenfeld, VirologYI in 
press). We have also used the increase in the relative rate of (+) strands early 
in the infection as a criterion to help identify a replication complex which has 
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been isolated (Simonsen, Hill, and Summers, submitted for publication). 
These results and future experiments should help us and others to better define 
the process of replication. 
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CHAPTER III 
CHARACTERIZATION OF VESICULAR STOMATITIS VIRUS 
REPLICATING COMPLEXES ISOLATED 
IN RENOGRAFIN GRADIENTS 
by 
Virginia M. Hill, Christian C. Simonsen and 
Donald F. Summers 
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Introduction 
Vesicular stomatitis virus (VSV) is an animal virus with an enveloped 
negative single-strand RNA. Contained in the genome, whose molecular weight 
is about 3.6 x 106 , is the information necessary to code for five virus-specific 
proteins: G and M, the envelope associated proteins; and N, NS and L, those 
proteins located in the virion ribonucleoprotein complex (1). The Land NS 
proteins are components of the RNA-dependent RNA transcriptase which, using 
the RNA genome-N protein complex as a template, synthesizes the five VSV-
specific messenger RNA (mRNA) species in vivo and in vitro (2-4). Replication 
of the VSV genome (synthesis of virion-length plus and minus stranded RNA 
species) occurs in vivo, and it has been presumed that the template was a ribo-
nucleoprotein (RNP) complex similar to that used for transcription (5,6). 
Studies on the mechanism of VSV replication have been hampered by the lack 
of an in vitro system capable of synthesizing virion RNA, and direct evidence 
as to the nature of the template is not available. 
During the VSV infectious cycle, at a time when VSV-specifi c RNA 
synthesis is maximol, about 90 percent of the RNA species being synthesized in 
the infected cell are the products of transcripti on; i.e " the 5 species of VSV 
mRNAs (Dr. Susan Batt-Humphries, personal communication), The remaining 
10 percent represents the full-length (42S) RNA molecules, both plus and 
minus strands. Early in infection the ratio of newly made full-length plus 
strand to minus strand is about 40:60, white later in infection the ratio chang~s 
to 20:80 (C. Simonsen, unpublished data, 5). The total intracellular pool of 
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RNP particles should contain transcribing complexes, RNP particles containing 
only minus strands which are to be assembled into virus particles and replicating 
complexes synthesizing 42S RNA molecules (if the replicating complexes are 
RNPs) . 
Transcribing complexes consist of a minus-strand template (425) upon 
which the mRNA species are syn·;·hesized. Replicating complexes should contain 
either a plus or minus stranded 42S RNS molecule, each serving as a template 
for complementary genome-sized RNA. 
Using short exposures to radiolabeled RNA precursors, we have pref-
erentially labeled nascent transcriptive and replicative products and have 
separated them on Renografin gradients. We have characterized the replicating 
complexes; the data indicate that the templates are RNP complexes. 
Materials and Methods 
Cells, virus infection and radiolabeling 
ofVSV RNA 
HeLa S3 ceJ Is and VSV Indiana were grown as previously described (1). 
Short-term labeling with [3H]-uridine and [3H]-adenosine (New England 
Nuclear) of infected cells was carried out as detailed in the figure legends. 
RNA extractions 
Appropriate samples from the Renografin gradients were peJleted and 
either resuspended in NETS buffer [100 mM NaCI, 1 mM EDTA, 10 mM Tris-
HCI pH 7.4, and 0.2% sodium dodecyl sulfate (NaDod50 4)] for further analyses 
on NETS-sucrose gradients or phenol extracted and then ethanol precipitated 
for RNA-RNA hybridization experiments or methyl-mercury agarose gel 
electrophoretic analyses. 
VSV-specific mRNA was isolated from infected cells at 4.5 hr post 
infection (PI) and purified through oligo (dT) cellulose which removed most of 
the rRNA. The RNA was then centrifuged in a sucrose gradient and the greater-
than-28S and less-than-18S RNAs were pooled separately. This process was 
repeated twice; the greater-than-28S RNA pool was used as a source of 31 S 
mRNA and the I ess-than-18S RNA as a source of the 12-18S mRNAs. The o. D. 
260 of each preparation was recorded, although the bulk of the RNA in each 
preparati on was 28S or 18S rRNA and therefore the amount of unlabeled RNA 
added to the hybridization mixtures reflects a mixture of the VSV mRNAs (31S 
or 12-185) r cel J mRNAs, and rRNA. VSV minus-strand 425 RNA was purified 
from phenol extracted viri ons and ethanol precipitated. 
Methyl-mercury agarose get electrophoresis 
The method for methyl-mercury gels was a modification of that described 
by Bailey and Davidson (8) using horizontal slab gels of 1% agarose and 5 mM 
methyl-mercury hydroxide (AI fa Products). The electrode buffer was recircu-
lated at 80 ml/hr; the samples were subjected to electrophoresis at 75 V I 45 rnA 
for 7-9 hr. After electrophoresis, the geJ was fixed in 10010 acetic acid and 
dehydrated in methanol by two immersi ons of 1 hr each. At this step, the slab 
gel was dried down to less than 0.5 mM thickness under vacuum and the thin 
slab was soaked in a solution of l00/c (w/w) 2, 5-diphenyloxazole (PPO) in 
methanol for 3 hrs at room temperature and rinsed in water for 15 minutes to 
precipitate the fluor. After blotting the excess H20, the gel was sealed in 
plasti c wrap and subi ected to autoradi ography with Kodak X -Omat fi 1m at 
_700 c. 
Results 
Presumably, by pulse-labeling VSV infected cells with radioactive 
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RNA precursors for short periods of time, much of the radioactivity would be 
incorporated into RNA molecules being synthesized by transcriptive and replica-
tive complexes. If one could identify RNP particles associated with radiolabeled 
nascent RNA species of heterogeneous sizes, 42S and smaller, and with a pre-
dominance of minus-strand sense, then one could assume that these structures 
were involved in replication. We pulse-labeled VSV-infected cells at 5 hr PI, 
a time when the rate of VSV replication is maximal (C. C. Simonsen, unpub-
lished data), and analyzed the cytoplasmic RNP species on Renografin gradients. 
Figure 1 A shows three predominant peaks of radioactivity from a VSV-infected 
cell cytoplasm, labeled 3 to 5 hr PI, on a Renografin gradient. A similar pat-
tern of radioactivity is seen after a 5-min pulse at 5 hr PI, except that peak 
I (fractions 15-20) is more heterogeneous (Fig. 1B). In some experiments this 
5-min pulse peak I resolved into two or more distinct peaks of radioactivity. 
When the entire peak I from the 2-hr label was pooled, the RNA 
released with NaDodSO 4 and analyzed on NETS-sucrose gradients, it is clearly 
shown (Fig. 2A) that the radio-labeled peak contained full-length (425) RNA 
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Fig. 1. Renografin gradients of VSV-infected cytoplasmic extract. Hela ceBs 
(2 x 108) in 20 mls MEM (serum-free) were infected with VSVat 10 PFU/cell 
at 37
0 
C. At 1 hr PI, serum and actinomycin D were added to concentrations 
of 5% and 1 ~gm/ml, respectively. At 3 hr PI the culture was divided in half 
and radiolabeled as described below: 
.A.. 2-hr pulse 
0.5 mC [3H]-adenosine and 0.5 mC [3 H]-uridine were added 
and the infection continued for 2 hr. 
B. 5-min pulse 
The i nfecti on was conti nued for 2 more hr at whi ch time (5 hr PI) 
5 mC [3 H]-uridine and 5 mC [3H]-adenosine, made isotonic with 
10 x Earle's salts and warmed to 370 C, were added for 5 min. 
At 5 hr PI, both cui tures were stepped by pouring the infected cells 
over frozen MEM and centrifuged immediately for 5 min at 1,000 rpm, using 
an I EC 267 rotor. The cells were washed once in Earl e r S sal ts and resuspended 
in 2-4 mls cold NT buffer (0.1 M NaCl, 0.01 M Tris-HCI pH 7.4), NP40 
(Shell) was added to a concentration of 1% to lyse the cells. After 5 min on 
ice, the nuclei were pelJeted by centrifugation at 1,500 rpm (lEC 267 rotor) 
for 3 min. The supernatant was removed and the nuclei resuspended in 1-2 mls 
of NT buffer. A mixture of NP40 and sodium deoxycholate was added to a 
final concentration of 0.3% and 0.2%, respectively. The nuclei were again 
pelleted, and the original and nuclear-wash supernatants were combined and 
layered onto Renografin gradients (Renografin 76, Squibb). 
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Preformed linear gradients were made in 36-ml cellulose nitrate tubes 
and contained 15-47% (v/v) Renografin in NT buffer. Gradients overlayed with 
cytoplasmic extracts were centrifuged at 23,000 rpm for 16 hr at 4 0 C in a 
SW27 rotor (Beckman). Gradients were collected in 60 fractions by pumping 
from the tube bottom. Renografi n is precipi tabl e by tri chr oroaceti c acid, 
perchloric acid and cetyltrimethylammonium bromide, and therefore radio-
activity was assayed by adding 501-A1 samples directly to a toluene-based scin-
tillation fluid (New England Nuclear). Sedimentation is from right to left in 
this and all subsequent figures. The radioactivity present in the very bottom of 
the gradient in Fig. 1 B represents trapped soluble radiolabel and is not 



























Fig. 2. Velocity sedimentation in sucrose gradients of 3H- RNA extracted from 
Renografin gradients. Samples from Renografin gradients were diluted in NT 
buffer, pelleted for 2 hr at 48,000 rpm in a SW50.1 rotor and resuspended in 
NETS buffer with J% NaDodSO 4. [14Cl-uridine-labeled VSV virion (425) 
RNA and HeLa-cell 28S and 18S ribosomal RNA were added as markers. The 
sampl es were centri fuged on sucrose (15-30% w /w) NETS gradients for 16 hr 
at 20,000 rpm at 22° C in a SW41 rotor. Gradients were collected by punc-
turing the bottom of the tubes; 18-frop fractions were dripped onto GFB What-
man filters which were washed successively with 10010 tricholoroacetic acid 
(TCA), mo 50/0 TCA rinses, and dehydrated with 95% ethanol. The filters 
were then assayed for radioactivity. In each case approximately 20% of the 
pools obtained from Fig. I were analyzed. 
A. Pool of fractions 12-18 from Renografin gradient - 2-hr label 
shown in Fig. 1 A. 
B. Pool of fractions 12-22 of the 5-min pulse shown in Fig. lB. 
C. Peak, fraction 16 of the 5-min pulse shown in Fig. 3B. 
D. Middle shoulder, fraction 18 of the 5-min pulse shown inFig.3 B. 
E. Light shoulder, fracti ons 20-21 of the 5-min pulse shown in Fig. 3 B. 
[14CJ-uridine label ed marker RNA • • 
[3H]-uridine labeled RNA from Renografin gradients 0 0 
(A)
 































































































































































































































































species which co-sedimented with virion 425 RNA marker and essentially no 
smaller mRNA-sized species were found in this peak. However, peak I from 
the gradient of 5-min labeled cytoplasm (Fig. 1 B) clearly contains a hetero-
geneous population of radiolabeled RNA molecules with sizes from 425 dOW'n to 
185 (Fig. 2 B). 
Figure 3 B is the portion of a Renografin gradient of a 5-min pulse-
labeled VSV-infected cytoplasm which contains peak I. Individual fractions 
of the radioactive peak shOW'n in 3 B (this peak corresponds to peak I, Fig. 1 B) 
were analyzed in NETS-sucrose gradients. The slower sedimenting fractions 
from the Renografin gradient seem to contain shorter nascent RNA molecules 
(Fi g. 2 D, E) . 
To rule out the possibility that the observed spectrum of labeled RNA 
species obtained from the peak (fractions 15-25) in Figure 3 B were largely or 
partl y due to doub Ie-stranded spe ci es (5), fracti ons from this Renografi n gradi ent 
were subjected to electrophoresis on denaturing methylmercury agarose gels 
(Fig. 3 A). It can be seen (Fig. 3 A, lanes B, C and D) that the three fractions 
selected from the slower sedimenting shoulder of the peak (Fig. 3 B, fractions 
18-26) contained RNA species of sizes less than 425 and of progressively smaller 
sizes. The peak fractions contained 425 RNA species and RNA with sizes rang-
ing from 425 down to smaller than 185 (Fig. 3 A, lane A). Also, treatment of 
fractions from NETS-sucrose gradients, similar to that shown in Fig. 2 B, with 
pancreatic RNase revealed no RNase-resistant species throughout the gradient, 
Fig. 3. Methyl mercury agarose gel analysis of the nascent RNA molecul es 
extracted from a Renografi n gradi ent. 
A. Methyl mercury agarose slab gel 
Lane A: RNA extracted From fractions 15-17 in 3 B. 
Lane B: RNA extracted from Fracti ~ns 18-19 in 3 B. 
Lane C: RNA extracted from fractions 20-22 in 3 B. 
Lane D: RNA extracted from fracti ons 24-26 in 3 B. 
B. Renografin gradient of a cytoplasmi c extract from VSV-inFected 
cel Is pul sed 5 mi n at 5 hrs PI. The condi ti ~ns for separati on 













































further indicaHng an absence of double-stranded RNA species in the RNA 
extracted from Renografin peak I (data not shown). 
It should be noted that a distinct band migrating at "26S II , which is 
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mi nus stranded (see be low), is seen in the methyl mercury gel (Fig. 3 A I lanes 
A and C). The nature of this band is unclear at this time. It is of interest that 
an in vitro transcribing system utilizing cytoplasmic VSV RNP's synthesizes an 
RNA species of similar size (Batt-Humphries, Simonsen and Ehrenfeld, Virology 
in press). Furthermore, multiple discrete bands smaller than 26S are seen in 
Figure 3 A, lane A. 
Since at 5 hr PI in the replicative cycle 80% of the replicating tem-
plates should be synthesizing minus-strand sequences, we tested by RNA-RNA 
hybridization to see if the polarity of the putative nascent RNA molecules iso-
lated in Renografin gradients was predominantly regative-stranded. As shown 
in Figure 4 A, under our conditions of hybridizati on, we could protect 100010 of 
labeled virion 42S RNA with a mixture of all five VSV mRNA species and could 
protect about 50% of the virion RNA with mRNA enriched for either the 31S L-
protein mRNA (complementary to the 5 1-half of the VSV genome) or the 12-18S 
mRNA species (G,M,NS and N mRNA species «2). When the peak fraction 
from peak.! (see Fig. 1 B) in a Rencgrafin gradient containing a 5-min pulse 
labeled infected cell extract was hybridized to an excess of cold total VSV 
mRNA or to excess cold virion RNA (Fig. 4 B).,. it can be seen that almost 100010 
~f the RNA species could be protected with the total mRNA, whereas the virion 
RNA afforded only 15% protection. This indicated that approximately 15% of 
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Fig.4. Hybridiza1"ion ofpufse-Iabeled RNA from Renografin gradients. 
Label ed RNA was phenol extracted and ethanol precipi tated from a Renografi n 
gradient similar to that in Fib. 3. Aliquots of the labeled RNA (approximately 
5 ng of specific activity 600,000 cpm/~g) were mixed with increasing amounts 
of unlabeled V5V-specific RNA heat denatured for 1 min at 1150 C, and 
hybridized for 3 hr at 730 C using the conditions of Kolakofsky (9). 
The radiolabeled RNA is: [3H]-425 RNA from virions (A)i [3 H]-RNA 
from a pool of Renografin isolated RNPs simi lar to that in Fig. 2, lane A, (8); 
[3H]-RNA from a sample similar to Fig. 3, lane C, (C); [3H]-RNA isolated 
from peak II, (D). 
The unlabeled RNA which was hybridized to each of these samples is: 
V5V genome 425 RNA (")i 12-185 and 315 mRNA mixture (.); 12-185 
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the labeled nascent RNA was (+) strand and that about 850/0 was (-) strand. 
This figure agrees with previous reports on the percentages of (+) and (-) full-
length RNA in the cell at this time (6). Due to the presence of unlabeled tem-
plate strands in peak I, addition of the unlabeled mRNA resulted in 100010 
protection and not 85% protection of the radiolabeled RNA in Fig. 4 B, as 
might othelWise be expected. 
I f the ~horter nascent strands (see lanes C and D / Fib. 3 A) were primar-
ily minus strands which were less than 50cro completed, they should be mainly 
composed of sequences from the L-protein cistron which is known to be located 
at the 51 end of the viri on RNA genome. We tested this hypothesis by separat-
ing the 315 L mRNA from the 12-185 V5V mRNAs and annealing these two 
mRNA size classes to RNA obtained from the pooled light shoulder of a 5-min 
pulse-labeled peak I from a Renografin gradient. Figure 4 C shows that the 
nascent RNA was protected by the sequences enri ched for the 315 mRNA spe ci es 
to a much greater degree than by that of the 12-185 mRNAs. The presence of 
unlabeled template strands of both polarities, and the fact that the nascent 
RNA sample contained some species larger than half genome size, resulted in 
the 12-185 mRNA probe protecting about 50010 of the sample and the 315 mRNA 
probe protecting approximately all of the sample. However, it is clearly shown 
in Fig. 4 C that the majority of the short heterogeneous pulse-labeled RNA 
molecules contained sequences complementary to the L mRNA and were thus 
products of replication. 
All of the Renografin gradients also contained a radi olabeled peak 
(peak II) at a lesser density than peak I (see Fig. 1). 5ince a mid-cycle of 
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infection approximately 900/0 of the VSV-specific RNA present represents trans-
cripts of virus mRNA and these RNA species are not represented in the Reno-
grafin peak I (Fig. 4 A/B,C), we concluded that the VSV transcriptive pro-
ducts must be in peak II or at the top of these Renografin gradients. To test 
this, peak II was pooled, the RNA was extracted and hybridized. As shawn in 
Fig. 4 D, this RNA was essentially 100010 plus-strand, and therefore likely to 
be mRNA. Pancreatic ribonucl ease treatment has shown that this RNA popula-
tion was 100010 sensitive to RNAse, as would be expected for free mRNA or 
mRNP complexes (6) (data not shown). Methyl-mercury gel analyses have also 
shown that peak II from a 5-min labeled extract contains RNA molecules 
heterogeneous in size, ranging from 4 to 205 (data not shown). Simi I ar resul ts 
were obtained with RNA pooled from the very top of these gradients which was 
shown to be identical to the VSV mRNA species (data not shown). 
Thus far, the data incidated that peak I in Renografin gradients of cyto-
plasm from 5-min pulses of VSV-infected cells contain nascent minus-stranded 
RNA molecules. To establish whether virus-specific RNP proteins (L, NS and/ 
or N) became associated with the growing 425 RNA strands during their synthe-
sis or after their completion, an infected culture was pulse-labeled for 5 min 
as above, a cytoplasmic extract was prepared and divided into halves, and one-
half was treated with pancreatic ribonuclease. Both the nuclease-treated and 
untreated samples were then analyzed in Renografin gradients. Figure 5 shows 
that the labeled RNA species in peak I (fractions 15-30) were completely 
nuclease resistant, and also shows that a large portion of the radiolabeled 
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Fig. 5. Ribonuclease-treated radiolabeled cytoplasmic extract fractionated 
on Renografin gradients. One-half of a cytoplasmic extract from VSV-infected 
cells, pulse-labeled at 5 hr PI, was treated with 10 ~gm/ml of RNAse for 30 
min at 200 c. 
Both extracts (treated and untreated) were then layered onto Renografin 
gradients and were centrifuged using the conditions given in Fig. 1. Assays of 
the radioactivity in the f'No gradients are superimposed in this figure: 
RNAse treated 8 8 
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materia I at the top of the gradient (re leased mRNA species) was nuc I ease sen-
sitive and could be seen as such, despite the large amount of soluble radio-
active uridine and adenosine in the top fractions of the gradient. The fact 
that the heterogeneous minus-stranded radi olabeled RNA molecul es in peak I 
are ribonuclease resistant, as are mature RNP s extracted from infecti ous virus 
particles or from infected cell cytoplasm (6), indicates that these partially 
repl icated RNA strands are probably closely associated with VSV protein(s) 
shortly following their initiation. Recent studies have also shown that these 
nascent RNP molecules have a density in CsCI gradients identical to that of 
virion RNP complexes (C. C. Simonsen, unpublished observations). We are 
now examining the protein(s) which rapidly associate with these nascent 
replicating RNA molecules. 
Discussi on 
In this study we have been able to partially isolate and characterize 
3H-uridine and 3H-adenosine pulse-labeled RNP complexes from VSV-infected 
cells. One of the peaks (peak I) in the Renografin gradients contains labeled 
RNA that is less than 18S to 42S in size. Almost all of this radiolabeled RNA 
is minus stranded. The nascent RNA that is less than 50010 full length is comple-
mentary to the L mRNA; since replication is initiated at the 3' end of the plus-
strand template (the 3' end of the plus strand contains the L protein cistron) 
and replication must proceed in the 5' to 3' direction on the progeny minus 
strand, these RNA sequences meet a basic requirement for being partially 
repl i cated mi nus-stranded RNA. 
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As replicating RNA strands are initiated and elongated, they become 
rapidly comp(exed with protein{s) which render these nascent RNA molecules 
resistant to nuclease digesti on. The data in Fig. 2 and our analyses of these 
RNA species with respect to nuclease sensitivity clearly show that there are no 
detectable double-stranded molecules in peak I. Since these nascent RNAs 
are nuclease resistant and band in CsCI at a density equal to that of virion 
RNPs, it is likely that the proteins on the newly made RNAs are VSV specific; 
i . e. I L, NS and/or N. 
Contained in peak I (Fig. 1 A and 1 B) are minus-stranded particles 
destined to become mature vi ri ons, mi nus-strand and pI us-strand structures that 
are replicating, and probably the minus-strand transcriptive template RNPs. 
Our results provide evidence that the template for VSV replication is an RNP 
complex similar to that involved in VSV transcription. It will be of importance 
to determine by what mechanism RNAs containing plus and minus strands are 
shunted to the pool of replicating or transcribing RNPs or to the pathway for 
viri on assembly. 
The Renografin gradients used to separate the replicating complexes, for 
unknown reasons, cause transcripi"ive complexes to dissociate and release their 
nascent mRNA chains. This points out that a structural difference must exist 
behNeen replicative and transcriptive RNP complexes. Post observations (11-
13) and recent studies in our laboratory with Renografin gradients (unpublished 
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results) have shown that the basis for separation of protein-nucleic acid com-
plexes in this medium is an approach to equilibrium in that some molecular 
species such as smaller RNP complexes are still being separated on the basis of 
velocity. We therefore cannot state with any certainty why peak I, containing 
5-min pulse-labeled RNA, have full-length 425 RNA molecules plus 
heterogeneous-sized nascent molecules down to less than 185 in size, and the 
slower sedimenting fractions contain nascent RNA chains of progressively 
smaller sizes. This observation might imply that sometemplates contain multiple 
r;ascent RNA chains which have somehow been initiated synchronously and, 
therefore, contain one or more RNA chains of a defined size class which are 
separable in Renografin. It is also possible that some templates contain a single 
nascent strand or that some of the nascent strands have dissociated from their 
templates. 
These results show that the nascent RNA mol ecul es extracted from the 
replicative templates (see Fig. 3 A) seem to occur as discrete size classes with 
a rather noticeable accumulation of a 11265 11 species (Fig. 3 A, lanes A and C). 
This may indicate that the V5V replicase polymerizes at a non-uniform rate 
with a major pause site at about 50Cla of the genome; i .e. , the L cistron. A 
simi lar phenomenon has recently been reported for the Q(3 polymerase (14) and 
had been observed in reverse transcriptase reactions as welt (15,16). 
The finding that intracellular V5V replicating complexes can now be 
isolated in Renografin gradients, coupled with the recent observation that an 
in vitro transcribing system derived from a VSV-infected cell extract wi II 
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synthesize full-length (425) RNA (Batt-Humphries, Simonsen and Ehrenfeld, 
Virology in press) now makes it feasible to develop an in vitro VSV replication 
system with which we can study the precise mechanisms of replication and 
packaging of newly synthesized 42$ RNA molecules. 
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CHAPTER IV 
FURTHER CHARACTERIZATION OF THE REPLICATIVE COMPLEX 
OF VESICULAR STOMATITIS VIRUS 
by 
Christian C. Simonsen, Virginia M. Hill and 
Donald F. Summers 
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Introducti on 
During the infection of HeLa cells by vesicular stomatitis virus (VSV), 
both virion (-) and complementary (+) full-length 42S RNA can be isolated 
from intracellular ribonucleoprotein (RNP) complexes (35, Simonsen, Batt-
Humphri es and Summers, submi tted for publi cati on). These RNPs are composed 
of 42S RNA and three VSV-specific proteins: The N, or nucleocapsid protein; 
the NS protein, a phosphorylated polypeptide; and the L protein (17,18,35). 
The virion nucleocapsid is able to direct the in vitro synthesis of the five VSV-
specifi c mRNAs which, like the in vivo VSV mRNAs, are capped at the 5' end, 
methylated, and polyadenylated (2,7,20,25,26,27,32). 
Reconstitution experiments have shown that the Land NS proteins are 
both required to form the virion-associated RNA-dependent RNA polymerase 
(17,18,28). The template for transcription has been demonstrated to be com-
posed of (-) strand 42S RNA and N protein (11,17). The requirements for 
replication, however, are not well known. The complementation group I 
temperature-sensitive mutant tsG 114, which possesses a thermolabile L protein 
(21), has been used to provide indirect evidence that the L protein is involved 
in replication (30), and several other mutants suggest a role in replication for 
the Nand NS proteins as well (15, 16). For these reasons it has been assumed 
that replication occurs on an RNP template simi lar to the transcriptive RNP. 
Fractionation techniques previously used to isolate VSV RNPs will not 
separate replicating RNPs from transcribing RNPs. Sedimentati on velocity 
centrifugati on analyses have indicated that intracellular VSV RNPs sediment 
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near 140Swhether or not mRNA is associated with the RNP complexes (31,34). 
The lack of resolution is further complicated by the fact that replication 
accounts for only 1 ()Olo of the total VSV-specifi c RNA synthesized in infected 
cerls (37); thus sucrose gradients have not been useful in separating replicating 
RNPs from transcribing RNPs. CsCI gradients have been used to isolate 
glutaraldehyde-fixed mRNPs (19) and intracellular nucleocapsids (Simonsen, 
Batt-Humphri es and Summers, submi tted for pubJi cati on)i however, the mRNPs 
are not stable in CsCI without prior fixation with glutaraldehyde and RNPs 
isolated in CsCI gradients do not retain the Land NS proteins, which are known 
to comprise part of the functional RNPs inthe cell (17,18). In addition, all of 
the intracellular RNPs band at the same density in CsCI. For these reasons, 
CsCI gradients have not been used to separate the RNP complexes. 
Iodinated density gradient media such as metrizamide and Renografin 
have been previously used to obtain resolution of proteins, nucleic acids, and 
ribonucleoproteins in the same gradient (8,12). They are hypertonic and mini-
mize non-specific RNA-protein interactions, yet RNPs remain intact. For these 
reasons, several investigators have previously employed iodinated density gra-
dient media to examine chromatin (12), influenza RNPs (10) and proteins (8). 
'vVe have recently described the isolation in Renografin gradients of pulse-
labeled RNPs from VSV-infected cells which appear to be replicating complexes 
(Hi II, Simonsen, and Summers, submitted for publication). Herein we extend 
these observations to examine the basis for the separation of the replicating 
RNPs in Renografin density gradients and further characterize the complexes to 
show by several different criteria that these RNPs are indeed replicative complexes. 
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Materials and Methods 
Cells, virus infection, and radioactive 
labeling 
Suspension cultures of HeLa S3 cells were grown in Joklik's modified 
minimal essential medium (Flow Laboratories) supplemented with 2 mM gluta-
mine plus 50/0 fetal calf serum (Flow Laboratories) at a concentration of 2-8 x 
5 10 cells per mi. Stock preparations ofVSV (Indiana serotype) were grown in 
HeLa cells, purified, and assayed as described previously (3,4). Cells were 
collected by centrifugation, resuspended in growth medium minus serum at a 
concentration of 6 x 106 cells per ml, and were then infected with 10 PFU of 
VSV per cell. At 1 h post-infection, serum was added to 50/0 and actinomycin 
D (a gift from Merck, Sharp and Dohme) was added to 'I-'g per mi. At times 
ranging from 2.5 h to 5 h post-infection, [3H]-uridine and/or [3H]-adenosine 
(25-30 Ci/mmol, New England Nuclear) were added to a concentration of 
200 fJCi per ml for the indicated labeling periods, after which crushed, frozen 
media was added and the cells were pelleted by centrifuging for 3 min at 
900 x g. The cell pellet was lysed by the addition of 1 ml of 10/0 NP-40 in 
NT buffer (0.1 M NaCl, 0.01 M Tris, pH 7.5) and kept on ice for 10 min. 
The nuclei were removed by centrifuging as above and were then resuspended 
in 1 ml of 0.2°k deoxycholate, O. 3°k NP-40 in NT buffer and recentrifuged. 
The supernatants from the 1% NP-40 treatment and the deoxycholate, NP-40 
wash were then combined and layered onto preformed CsCI or Renografin 
gradients. 
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Isolati on of RNP complexes 
RNPs were isolated using either Renogratin, CsCI, or sucrose gradients. 
For isolation of the replicative RNPs, the cytoplasmic extracts from above were 
layered onto preformed 36 ml 15-50010 or 20-60010 Renografin (E. R. Squibb and 
Sons) gradients in NT buffer and centri fuged at 23,000 rpm at 4 0 C in the 
SW-27 rotor for 16 h (for nonequilibrium gradients), or for 80 h (for equilibrium 
gradients). The gradients were fracti onated by pumpi ng from the bottom and 
radioactivity determined by directly assaying 50'll' samples in 7 ml of scintilla-
tion cocktail in a Beckman liquid scintillation spectrometer. 
Preformed 20-40% (w/w) CsCI (Varlacoid Chemical Company) gradients 
in TNE buffer (0.025 M Tris-HCI, pH 7.5, 0.05 M NaCI, 0.002 M EDTA) 
were overlayed with fracti ons from the Renografin gradient whi ch had been 
diluted 1:3 in NT buffer. These gradients were centrifuged in the SW-41 rotor 
at 33,000 rpm for 16 h at 40 C. After centrifugation, the gradients were 
fractionated and acid-precipitable radioactivity was determined as described 
previously (3,4). Density of the fractions was determined by measuring the 
refractive indices using a Bausch and Lomb refractometer. 
Cytoplasmi c extracts were also layered onto 15-30010 sucrose gradients 
in NT buffer which were centrifuged in the SW-27 rotor for 16 h at 16,000 rpm 
at 4 0 C and fracti onated as above. 
Phenol extracti on of RNA 
An equal volume of NETS-saturated phenol (0. 1 M NaCI, 0.001 M 
EDTA, 0.01 M Tris, pH 7.5, 0.2% SDS) was added to the samples in 3 ml of 
NETS, mixed, and the two layers separated by centrifugation. The aqueous 
layer was collected, and the phenol layer was extracted once more with 3 m I 
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of NETS buffer. The aqueous fractions were combined, sodium acetate added 
to a final concentration of 0.2 M, two volumes of ethanol added, and the RNA 
precipi tated at _700 C overnight. RNA was pe II e ted by centri fugati on at 
16, 000 x g for 30 min at 40 C . 
Purification of VSV-specific RNA 
Minus-strand 42S RNA was prepared from purified virions by disrupting 
the virus in NETS buffer and centrifuging the samples in 15-30010 sucrose-SDS 
gradients in the SW-41 rotor. The 42S RNA peak was ethanol precipitated and 
dissolved in 2 x A buffer (0.3 M NaCI, 0.02 M Tris/ pH 7.4, 0.002 M EDTA). 
VSV mRNA was prepared from infected cells at 4.5 h post-infection. A cyto-
plasmi c extract was prepared as described and was phenol-extracted/ ethanol 
precipitated, and chromatographed on an 01 igo (dT) cellulose col umn. 
Oligo (dT)-cellulose chromatography of 
RNA 
01 igo (dT)-cell ulose (Collaborati ve Research, Inc., Wei tham I Mass.) 
columns were prepared and eluted according to Banerjee and Rhodes (8). The 
high salt-elution buffer contained 0.01 M Tris-HCI I pH 7.4,0.5 M NoCI, 
and the low salt buffer contained 0.01 M Tris-HCI, pH 7.4 RNA was loaded 
onto the column in high-sal t buffer. FracH ons contai ni ng bound material were 
pooled and ethanol-precipi tated as described above. 
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Hybridization of VSV RNA 
Hybridizations were performed in sealed capillary pipettes in 0.02-m1 
volumes using the conditions of Kolakofsky (24). To each aliquot of [3H]-RNA 
isolated from nucleocapsids was added increasing amounts of unlabeled VSV 
virion 42S RNA or mRNA. The samples were then heat-denatured by heating 
to 1150 C for 3 min and incubated 3 h at 73 0 C. Each sample was treated with 
a 30iJg/ml solution of Ribonuclease A (Worthington) in 2 x A buffer for 30 min 
at 250 C and was then assayed for acid-precipitable radioactivity as described 
above. The self-annealing reactions were identical except that no unlabeled 
RNA was added to the samples. 
Methyl mercury-agarose gel electrophoresis 
Methylmercury-agarose gel electrophoresis was performed according to 
a modi fi catj on of Bai I ey and Davi dson (5). Seakem agarose powder was ob-
tained from Marine Colloids t Inc. and methylmercury (11) hydroxide was 
obtained as a 1 M sol uti on fro Alfa Products, Danvers, Mass. Because of the 
toxi c and volati Ie nature of the mercury compound t operati ons were performed 
under a hood. Horizontal slab gels (19 cm x 13.3 cm x 0.4 cm; 100 ml bed 
volume) were 1~'c, agarose in borate buffer (0.05 M boric acid, 0.005 M sodium 
borate, 0.01 M sodium sulphate and 0.001 M trisodium EDTA, pH 8.0), and 
contained 0.005 M methylmercury hydroxide. Samples were applied in 40 iJl 
of 1: 1, sample: sample buffer (borate buffer contai ni n9 50010 glycerolt O. 10/0 
bromophenol blue) with methylmercury hydroxide added to a concentrati on of 
0.005 M just prior to loading onto the gel. The gel reservoirs contained borate 
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buffer, and this buffer was reci rculated at approximatel y 80 ml per h throughout 
the electrophoresis period. Gels were run at 75-100 V (50 mA) for 6 h (dye 
front migrated 14 cm). 
Ffuorography of methylmercury gels 
Gels containing [3H]-RNA were fixed for 10 min in 10% acetic acid 
containing 0.01 M cysteine. They were dehydrated in 1000A, methanol for two 
successive l-h periods. After drying down to paper thinness under vacuum, 
the gels were soaked in a 1~'o (w/v) solution of 2,5-diphenyloxazole (PPo; 
New England Nudear, Boston, Mass.) in methanol for 3 h. Gels were soaked 
in water for 10 min to precipitate the PPO, blotted dry and mounted on a piece 
of 3 MM paper (VVhatman, Ltd., England). After covering with Saran Wrap, 
o 
gels were exposed to Kodak X-ray SB-5 film at -70 C and developed after 
appropriate peri ods of time. 
Resul ts 
Kineti cs of label ing of the nascent RNA 
We have previously reported the isolation in Renografin gradients of 
ribonucleoprotein complexes from VSV-infected HeLa cells which had been 
pulse-labeled for 5 min at 5 h post-infection (PI) with [3H]-uridine and [3 H]_ 
adenosine (Hill, Simonsen, and Summers, submitted for publication). When 
such an infected radiolabeled cell extract was centrifuged in a preformed 
15-47% Renogra fi n grodient, a comp lex was observed as a broad peak (Peak I) 
at a peak density of 1.240 g/cm3 with a pronounced trailing edge. Full-1ength 
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and smdller V5V-specific RNA was found in the peak fraction, and less than 
full-length RNAs were contained in the trailing edge of the peak. This pulse-
labeled nascent RNA was shown to be 800/0 (-) strand, the same percentage 
observed with pulse-labeled 425 RNA containing nucleocapsids isolated from 
V5V-infected cells at 5 h PI when VSV replication is maximal (Simonsen, Batt-
Humphries, and Summers, submitted for publication). The nascent (-) RNA 
was shown to be identical to the 5' end of the genome and was contained in a 
ribonuclease-resistant form even though it was single-stranded. A second peak 
(Peak II) was found at 1.15 gm/cm3 and was shown to contain only nascent 
mRNA species. 
In order to determine if radi olabel would accumulate as 425 RNA in 
Peak I RNPs labeled longer than 5 min, VSV-infected HeLa cells were incu-
bated in the presence of [3HJ-uridine and [3Hl-adenosine; aliquots were 
removed at 5, 10, 15 and 30 min after the addition of the label. Cytoplasmic 
extracts were prepared and layered onto identical preformed 15-500k Renografin 
gradients and centrifuged. The results shown in Fig 1 demonstrate that the 
broad distribution of radioactivity observed with the 5-min pulse becomes pro-
gressively more homogeneous as the labeling time increases; i .e., the samples 
labeled for 15 or 30 min do not have a trailing edge in the Renografin gradients 
as does the 5-min pulsed sample. The radioactivity at the very bottom of the 
gradi ents represents trapped sol ubi e radi olabel, and it is not recoverable by 
high-speed centrifugation as is the radioactivity present in Peak I, II, or at 
the top of the gradi ent. 
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Fig 1. Renografin gradient centrifugation of cytoplasmic extracts from pulse-
labeled YSY-infected cells. Infected cells at 4.5 h PI were labeled with 100 
~C/ml each of r3H]-adenosine and [3H]-uridine. Samples were removed at 5/ 
10, 15 and 30 min after the addition of the label. Cytoplasmic extracts were 
prepared, layered onto 15-509'0 Renografin gradients and were centrifuged for 
17 hat 23,000 rpm at 40 C in the SW-27 rotor. Fractions (0.5 ml) were 
collected by pumping out from the bottom and the radioactivity in each fraction 
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The labeled RNA species associated with these replicating RNP com-
plexes were then studied in denaturing agarose gels. As seen in Fig 2, the 5-
min labeled RNA is quite heterogeneous in size, ranging from full-length 42S 
RNA to a size which is less than the 18S rRNA marker, although the average 
size of this sample is approximately 26S. The size distribution of the 10-min 
sampre is also heterogeneous; however, the average size of the labeled RNA 
has increased to a value of approximately 35S, and there is a clear 42S band. 
Both the 15-min and 30-min samples contain predominantly 42S RNA, although 
there are signifi cant amounts of heterogeneous material less than 42S RNA in 
size. This suggests that the radi olabel accumulates as genome-length RNA as 
the pulse-ti me increases. 
Hybridization of pulse-labeled RNA 
from Peak r RNPs 
We have previously reported that the ratio of plus to minus 42S RNA 
synthesis in infected cells is greater early in the infection (2.5 h PI) than when 
replication is maximal at 5 h PI, at which time 80% of the newly synthesized 
42S molecules are (-) strand (Simonsen, Batt-Humphries, and Summers, sub-
mitted for publication). We have also shown that pulse-labeled nascent RNA 
species which were isolated from putative replication complexes at 5 h PI were 
approximately 80010 minus-strand (Hill, Simonsen, and Summers, submitted for 
publ icati on). 
In order to determine if pulse-labeled nascent RNA extracted from the 
replication complexes reflect the in vivo findings, infected HeLa cells were 
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Fig 2. Densi tometer traces of fluorographed methylmercury agarose gels of 
RNA. The RNA contained in the pulse-labeled RNPs was extracted from the 
RNP pools indicated in Fig 1. The RNA was electrophoresed in a methylmercury-
agarose gel and autoradi ographed as described in the Materials and Methods. 
The exposed film was analyzed using an Ortec model 4310 densitometer. 















~ t ! 
2 4 6 8 






labeled for 5 min with [3 H]-uridine at 2.5 h PI and at 5 h PI. Cytoplasmic 
extrac ts were prepared from these ce II s and were centri fuged in 15-500/0 Reno-
grafin gradients. The nascent RNA contained in the RNP complexes (at a peak 
density of 1 .240 g/cc) was hybridized with unlabeled V5V 425 RNA and V5V 
mRNA. The RNPs were found to contain signifi cantly more (+) strand RNA 
than the RNPs labeled at 5 h PI (Table 1). This indicates that the (+) strand 
RNA isolated from the Peak I RNP complexes is a product of replication and not 
transcription since the complexes isolated in Renografin reflect our previous 
observati on that the rati 0 of (+) : (-) 425 RNA synthesis is greater at 2 h PI than 
at 5 h PI. 
Effect of cycloheximide on the 
replicative RNP 
A further means of differentiating the rep I icative process from the tran-
scriptive process is by using the protein synthesis inhibitor cycloheximide. The 
synthesis of the V5V mRNAs is not affected appreciably by the addi ti on of 
cycl oheximi de, whereas repl icati on of 425 RNA is rapi dly inhi bi ted (30,37). 
Fig 3 shows that the synthesis of the Peak I RNP compl ex from Renografi n is 
inhibited by the addition of cycloheximide while the formation of the slower 
sedimenti n9 Peak II, whi ch contai ns excl usi ve Iy (+) strand sequences (Hill, 
Simonsen and Summers, submitted for publication), is unaffected by the addition 
of the drug. This result also demonstrates that the cycloheximide-sensitive 
RNP complex is a replicative complex. 
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unlabeled RNA added 
total se I f anneal ed mRNA 42S RNA 
p ost-i nfecti on cpm cpm % cpm % cpm 0/0 
2.5 776 298 38 545 70 266 34 
2.5 707 277 39 488 69 247 35 
5 1247 407 33 1175 94 225 18 
5 572 192 33 544- 95 60 10 
Table 1 
Hybridization analysis of the RNA isolated from replicative RNPs from 
cytoplasmi c extracts pulse-labeled at 2.5 and 5 h PI. Infected cells were 
pulse-labeled at either 2.5 or 5 h PI as described in Fig 1. The replicative 
RNP compl ex was isolated from non-equi Iibrium Renogratin gradients and the 
RNA contained in the RNP was isolated by phenol extracti on. 
The pulse-labeled RNA was mixed with increasing amounts of unlabeled 
VSV mRNA or 42S RNA in 20,.11 reaction volumes using the conditi ons of 
Kolakofsky (25). The samples were heated to 1150 for 1 min, annealed for 3 h 
at 730 (, and then treated with 30 tlg/ml ribonuclease A in 2 x A buffer for 
30 min at 22 0 (. Plateau levels of ribonuclease resistance are expressed in 
the table after being corrected for the ribonuclease-resistant material which 
was present when the sample was heat-denatured but not annea led. This figure 
varied from 2-4% of the input radioactivity. Self-annealing of the material 
was determi ned as for the above except that no unlabeled RNA was added to 
the complex. 
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Fig 3. Effect of cycloheximide on the production of replicative RNP complex. 
A culture of infected cells was split in half at 4.5 h PI and to one-half of the 
culture cycloheximide was added to a final concentration of 100 ~g/ml. After 
15 min in the presence of the drug, [3Hl-uridine was added to each culture to 
a final concentration of 100 ~C/ml. After 5-min incubation, the cells were 
removed by centri fugati on and cytoplasmi c extracts were prepared as described 
in the Materials and Methods. The extracts were layered onto separate identi-
cal 15-500k Renografin gradients and were centrifuged for 16 h at 23,000 rpm 
at 4 0 C in the SV";-27 rotor. The radioactivity from the fractionated gradients 
was analyzed as described previously . 
... ----. untreated control; a---------. cycloheximide-treated sample. 
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lsopycnic gradient centrifugation of the 
replicative complexes 
98 
We next examined the RNP complexes in isopycnic Renografin gradients 
in order to study the basis for the isolation of the heterogeneous Peak I. This 
peak contains progressively smaller nascent RNA species in the trailing frac-
tionsofthepeak (Hill, Simonsen, and Summers, submitted forpubIication). 
A cytoplasmic extract was prepared from cells pulse-labeled for 5 min at 5 h 
post-i nfecti on as described in the Material s and Methods and was centri fuged 
in a 15-50% Renografin gradient for 17 h at 23,000 rpm in the 5W-27 rotor. 
Fracti ons from three parts of the RNP peak were pooled as i ndi cated 
(Fig 4A), combi ned, and al iquots were recentrifuged on identi cal 20-60% gra-
dients for 17,50 and 80 h (Fig 48,C,D). The replicative RNP peak, which 
was very heterogeneous after bei ng recentrifuged for 17 h (Fig 4B), formed a 
homogeneous peak at a density of 1 .248 g/cm3 in the isopycnic gradients (Fig 
4C,D). Under the same conditions of centrifugation, V5V 425 RNA is found 
at 1 .19 g/cm3 (Fig4E). Poliovirus top component (nucleocapsid which lacks 
RNA) and poliovirus infectious particles are found in the equilibrium gradients 
at 1.325 gm/cm3 and 1.218 gm/cm3, respectively (Fig 4F). The result indi-
cated that the rati 0 of protei n to RNA in the nascent RNPs was the same 
throughout the replicative complex since the smaller RNPs contained in the 
trai I ing edge of Peak I had the same isopycnic density in Renografin. 
The nascent RNPs were further analyzed by centrifuging fractions from 
the peak and trailing fractions of Peak I from a Renografin gradient in CsCI 
Fig 4. Equi I ibri um Renografi n densi ty gradi en t centri fugati on of the 5-m in 
labeled RNP complex. Infected cells at 5 h PI were labeled by the addition 
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of 100 JlC/ml each of [3Hl-uridine and [3H]-adenosine. Crushed, frozen media 
was added to the sample after 5 min in the presence of the label, and the cells 
were removed by centrifugati on. A cytoplasmi c extract was prepared end 
layered onto a 15-50010 Renografi n gradi ent whi ch was centri fuged for 16 h at 
23,000 rpm at 4 0 C in the 5W-27 rotor. The radioactivity was quantitated as 
described in the Materials and Methods. The fractions indicated from the peak 
and trailing fractions in panel A were combined and diluted. Aliquots were 
layered onto identi cal 20-60% Renografin gradients and were centrifuged at 
23,000 rpm at 4 0 C in the 5W-27 rotor for 17 h, B; 40 h, C; 80 h, D. [3 H]_ 
425 RNA, Ei and poliovirus nucleocapsid and top component, Fi were centri-































































































































































































































































































































































































gradients. Fig 5 demonstrates that the nascent labeled RNPs have a similar 
protein: RNA ratio in CsCI as do virion nucleocapsids since all of the radio-
activity was found at a density of 1.31 g/cm3 . The CsCI removes the Land 
NS proteins from the nucleocapsid (17,29); thus it is likely that N protein and 
nascent RNA alone account for this resul t. The RNA contai ned in the nascent 
nucleocapsid-like RNPs was then analyzed in sucrose-SDS gradients which 
showed that the RNA contained in the CsCI banded RNPs was nascent RNA 
and not just 42S RNA (Fig 6). The demonstrati on that the nascent RNPs are 
stable in CsCI is further evi dence suggesting that these nascent RNPs are 
derived from a replicative intermediate because transcriptive products will not 
band in CsCI (19). 
Stability of the nascent and template 
RNPs in Renografin 
A likely explanation for the obs·ervance of the broad Peak I is that 
some of the nascent and template RNPs dissociate in Renografin and that the 
trailing fractions of Peak I are being separated from the peak fractions on the 
basis of size. It is clear that samples which are pulse-labeled for longer periods 
of time produce a narrow I homogeneous Peak J (Fig 1) cnd that there is a con-
siderable amount of I ess-tha n-fu I I-length RNA in these samples (Fig 2). This 
suggests that nascent RNA and template RNP remain associated in the peak 
fractions, but not in the trailing fractions. 
The direct size analysis of the nascent RNPs contained in Peak I was 
performed in sucrose gradients which indicated that the pulse-labeled RNPs 
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Fig 5. CsCI gradient centrifugati on of Peak I from a Renografi n gradient. A 
cytoplasmic extract from infected cells pulse-labeled for 5 min at 5 h PI was 
layered onto a 15-50010 Renografin gradient and centrifuged as for Fig 1. The 
RNP peak was split into three pools as indicated in Panel A. The pools were 
then layered onto 20-40010 (w/w) CsCI gradients in TNE buffer and centrifuged 
for 16 h at 33,000 rpm at 4 0 C in the SW-41 rotor. 0.5-ml fractions were 
collected from the bottom, TCA precipitable radioactivity was determined for 
250 \-11 of each fraction, and the density recorded by measuring the refractive 
indi ces of the fracti ons on a Bausch and Lomb refractometer. CsCI gradi ent of 


































































































Fig 6. Size anaJysis of the pulse-labeled RNA contained in CsCI banded 
replicative RNPs. The pulse-labeled RNPs which were banded in CsCI in Fig 
5 B ... C, D w~re phenol-extracted, and the RNA contained in these complexes 
was centrifuged in 15-30% 5ucrose-SDS gradients for 16 h at 20,000 rpm in the 
SW-41 rotor. TCA-precipitable radioactivity was determined for each of the 
fractions which were collected by dripping from the bottom of the tube. [14C]_ 
uridine labeled 42S, 28S, 18S.1 and 4S markers, 0---0; [3H]-uridine labeled 
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from the trailing fractions of Peak I had a slightly smaller sedimentation coeffi-
ci ent than the RNPs from the peak FracH ons; however, the resul ts were i ncon-
clusive due to the aggregation of the RNPs when removed from Renografin and 
the poor resolution of sucrose gradients we observed in this size range (data not 
shown). This matter was therefore examined indirectly by comparing the 
behavior of defective-interfering (01) particle nucleoccpsids in Renografin to 
the trailing fraction of Peak I. We reasoned that the DI-RNPs, wh.ich also 
band in CsCI at 1.31 g/cm3 (M. Leppert, personal communication), should be 
found in the same regi on of a nonequi I ibri um Renografin gradi ent as the nascent 
RNPs found in the trailing fractions of Peck I if these nascent RNPs are, in fact, 
dissociated from thei r templates. Fig 7 shows that the nucl eocapsi ds derived 
from a strain of 01 particles, which contain a genome which is only 15% of the 
wild-type genome (5ue Moyer, personal communication), are found in exactly 
the same reg; on of a ncn-equi I ibri urn Renografi n gradi ent as are the nascent 
RNPs which are about 15% replicated (Fig 7A, B; density of 1.18 g/cm3). The 
OI-RNPs presumably have the same structure as do the nascent RNPs since they 
have identical densities in both isopycnic Renografin (Fig 7C) and CsCI gra-
dients. This suggests that the RNPs contained in the trailing fractions are 
dissociated frorn their templates and are being separated from the peak fractions 
on the basis of size. We have observed that 425, 285 and 18S RNAs are re-
solved as three peaks in a 15-50010 Renografin gradient under conditions which 
are in equilibrium for the RNPs; thus these gradients can resolve at least RNA 
molecules on the basis of size (data not shown). However, we cannot exclude 
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Fig 7. Comparison of RNPs derived from DI particles to the replicative RNP 
complexes. [3H]-DI particles of the MS-T strain were purified by rate zonal 
sedi mentati on in sucrose gradients. The puri fi ed preparati on was adj usted to a 
concentration of 0.2% DOC, 0.30/0 NP-40 in NT buffer and divided into two 
samples. One sample was layered onto a 15-50% Renografin gradient while 
the other was layered onto a 20-60C3'o gradient. Both were centri fuged at 
23,000 rpm at4° C in the SW-27.1 rotor. Fractions were analyzed as for 
Fig 1. Cytoplasmic extract from 5-min pulse-labeled cells centrifuged in a 
15-500/0 Renografin gradient for 16 h at 23,000 rpm in the SW-27. 1 rotor, Ai 
DI-RNP centrifuged for 16 h in the 15-500/0 Renografin gradient, B; and DI-
RNP centrifuged for 80 h in the 20-600/0 Renografin gradient, C. 
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A Peak I Peak II 1.22 1.18 1.14 
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the possibility that conformational factors cause some of the nascent RNPs to 
move more slowly through the Renografin gradient, thus forming the trailing 
edge. 
The effect of Renografi n on transcribi ng 
complexes 
The total intracellular viral RNPs consist of transcribing complexes t 
non-enveloped.virion RNPs to be assembled into virus particles t and replicating 
complexes. Previous studies have shown that intracellular RNPs co-sediment 
with virion RNPs in sucrose gradients as 120S-1405 molecules t even though 
mRNA can be detected associated with these intracellular RNP complexes (31, 
34). We also wished to examine the behavior of these 120S-140S RNPs in 
Renografin gradients. 
A cytoplasmic extract was prepared from VSV-infected cells pulse-
labeled for 5 min at 5 h post-infection. The extract was divided into two 
samples; one was centrifuged in a 15-470/0 Renografin gradient (Fig 8A) while 
the other sample was centrifuged in a 15-309iJ sucrose gradient (Fig aB). The 
peak fractions from the Renografin gradient in Fig 8A which contained the 
replicative complex were combined as indicated and recentrifuged in a 20-47~/o 
Renografin gradient (Fig 9C). All of the radioactivity was found in the area 
of Peak I and no material was found in the reg i on of the gradi ent where the 
nascent mRNA species have been isolated (Peak /I). Fracti ons from different re-
gions of the140S peak in the sucrose gradient (Fig 8B) were also pooled as indi-
cated and recentrifuged on identi cal 20-470/0 Renografi n gradients (Fig 8D, E, F). 
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Fig 8. Renografin gradient centrifugation of RNPs obtained from Renografin 
and sucrose gradients. A cytoplasmi c extract from cells pulse-labeled for 5 min 
was prepared as for Fig 1. The sampl e was divi dedi one-hal f was layered onto 
a 15-500k Renografin gradient, and the other half of the sample was layered 
onto a 15-30% sucrose gradient. Both were centrifuged for 16 h at 23,000 rpm 
at 4 0 C in the SW-27 rotor. Fracti ons were removed from both gradi ents and 
recentrifuged in 20-47% Renografin gradients for 16 h at 23,000 rpm in the 
SW-41 rotor. Cytoplasmic extract centrifuged in a 15-500k Renografin gra-
dient, Ai cytoplasmic extract centrifuged in a 15-300k sucrose gradient, B; 
pooled fractions from Renografin gradient in panel A rerun in a 20-47% Reno-
grafin gradient, Ci fraction 18 from the sucrose gradient in panel B recentri-
fuged in 20-47~'o Renografin gradient, Di fraction 21, from B recentrifuged in 
a 20-47% Renografi n gradi ent, E; frecti on 24, from B recentri fuged ina 20-47% 
Renografin gradient, F. The sedimentati on positi on of the 60S and 405 ribo-
somal subunits and the viri on RNP are indicated in panel B by the arrows. 
The material in panel D, fractions 5-7, which is found at a greater 
density than peak I, represents a conformer of peak I. The nature of this 













































































































































































































The results of these three gradients are virtually identical; in addition to the 
material at Peak (, a peak at the position of Peak II was observed. Although 
transcripti on accounts for nearly 90% of the total RNA synthesis in VSV-
infected cells (38), Peak II does not represent 90010 of the input radioactivity 
because the mRNA which is completed during the pulse is not found in Peak II. 
The fully synthesized messages are found at the top of the non-equi librium gra-
dients as free RNA (data not shown). These resul ts demonstrate that the 1405 
RNPs isolated in sucrose gradients contain both transcribing and replicating 
RNP complexes in the same proportions throughout the 1405 peak and that repli-
cating molecules can be separated from transcribing molecules in Renografin 
gradients due to some undetermined compositional and/or structural differences. 
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Discussi on 
The ability of the VSV ribonucleoprotein core isolated from virions to 
transcribe in vivo and in vitro has been well documented (2,7,20,25,26,27, 
32). The transcriptase enzyme has been shown to be composed of the Land NS 
proteins, and the template has been demonstrated to consist of (-) strand 42S 
RNA and N protein (17,18,28). The enzyme is inactive with 42S devoid of 
protein or in the presence of antibody directed against the N protein-RNA 
complex (11,17). It thus seems well established that the template for tran-
scription is an RNP complex. It has been assumed that the template for repli-
cation is also an RNP complex on the basis of genetic studies with ts mutants. 
Several mutants in group I (L protein), group II and group IV (presumably N 
and NS proteins) have temperature-sensitive replicative abilities (15,16,30). 
Direct evidence for the role of these proteins in replication is racking due to 
the absence of an in vitro replication system. The data presented above and in 
our previ ous report (Hi II, Simonsen, and Summers, submi tted for publicati on) 
support the hypothesis that VSV repl i cati on occurs on an RNP tempi ate. 
The nuclease-resistance and densi ty of the nascent RNP compl exes is an 
indication that the nascent RNA species found in the RNPs are quickly associ-
ated with protein. Preliminary results from this lab have indicated that the 
proteins which rapidly associate with the complex are indeed the VSV L, NSf 
and N proteins. The association of these proteins with the nascent RNA is 
intriguing since this may be the process with which cycloheximide interferes 
and thus inhibits replication. The strong association of N pretein with 42S 
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RNA that has been observed (9) is not seen with the VSV mRNA species, even 
though the nucleotide sequences of the mRNA are a subset of the (+) 425 RNA 
sequence. The "Ieaderll RNA r which is identical to the first 48 nucleotides at 
the 5' end of the (+) 425 RNA (13, 14) is not found in the messages and thus 
could contain a sequence which acts as a binding site for the N protein. Hovv 
ever, the "leader" is not found in the infected cell as a short RNP, which 
would be expected if the leader alone were the signal for the association of 
N protein with the nascent RNA (Simonsen, unpublished observati ons). The 
addition of N protein to the nascent RNA may well be an integral part of rep li-
cation associated with the replicase enzyme or template. This would account 
for the nuclease-resistance and densi ty in CsCI of the nascent strands. We are 
presently examining the mechanism by which cycloheximide inhibits replication 
as well as the kinetics of protein association with the nascent replicated RNA. 
The data also suggest that most of the nascent RNPs remain associated 
with their RNP templates, although some of the pulse-labeled RNPs dissociate 
from their templates and cause a trailing edge to form in Peak I. VVe have 
observed that the very homogeneous Renografin peaks from samples pulse-labeled 
for 15 and 30 min (Fig 1C,D), and the peak fraction of a 5-min pulse-labeled 
sample (Fig 6A) contain RNA ranging in size from 425 down to less than 18S; 
however, the trailing fractions of Peak I contain primarily less than full-length 
RNA (Fig 6C). The observation that RNPs derived from DI particles which 
have a genome approximately 15% of the wild-type genome co-sediment with 
nascent RNPs from the trailing edge which are also 15°k completed lead us to 
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believe that the trailing fractions do contain nascent RNPs which are no longer 
attached to their templates. It is possible that the trailing fractions are associ-
ated with their templates but that conformati onal differences or an increased 
proportion of nascent strands cause the molecules in this region of the gradient 
to sediment more slowly than the RNPs in the peak fracti ons. 
Our results are consistent in establishing that nascent replicating RNA 
is found as part of a ribonucleoprotein. We have not found any evidence for 
the presence of double-strand RNA in these complexes (Hilt, Simonsen, and 
Summers, submitted for publi cati on). We suspect that doub Ie-stranded RNA 
molecules v/hich have been examined (36) as possible rep/i cative intermediates 
are perhaps artifacts of isolation. Since the structures we have isolated appear 
to contain template and nascent strands, presumably linked by the replicase 
enzyme or a small region of base pairs, ,the addition of phenol to remove pro-
tein would likely enhance the hybridization of these complementing RNA 
molecules which are already in close proximity (30). Hybridization in phenol 
emulsions is known to greatly increase the rate of annealing (24). It thus 
seems reasonable to accept the phenol-extracted double-stranded RNA mole-
cules as IIcollapsed ll replicative complexes, which probably approximate cer-
tai n aspec ts of rep I i cati on. 
The isolation of a replicative complex, coupled with the recent demon-
stration of full-length VSV RNA synthesis in vitro (Batt-Humphries, Simonsen, 
and Ehrenfeld, VirologYI in press), may now make it feasible to develop in 
vitro replication system using the complexes isolated from Renografin. The 
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reconstituti on of a replication system is clearly required in order to fully 
understand the regulation of replication and the role of host factors in VSV 
replication. We are currently attempting to study this system in greater detail. 
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Impl i cati ons 
Modulation of 425 RNA synthesis in vivo 
We have shown by pulse-labeling Y5V-infected cells and performing 
hybridization analyses on the pulse-labeled 425 RNA contained in intracellular 
nucleocapsids that the synthesis of 425 RNA in vivo results in a shift in the 
ratio of (+): (-) 425 RNA from 40: 60 at 2 h post-infection (PI) to 20 :80 at 
6 h PI. The shift is caused by an apparent increase in the rate of (-) strand 
425 RNA synthesis and a constant rate of (+) strand 425 RNA synthesis. We 
have observed this result by pulse-labeling cells at various times in the infection 
and measuring the rates of (+) and (-) strand synthesis. We have also observed 
this by directly quantitating the number of (+) and (-) strands in the cell 
throughout the infecti on. 
Our results may be best explained by proposing that there are separate 
host or viral factors involved in the synthesis of each of the polarities of 425 
RNA. The accumulation of a factor required for the synthesis of (-) strand 425 
RNA might explain the increase in the rate of synthesis of the (-) strands 
throughout the infecti on, but it does not account for the observati on that the 
rate of (+) strand 425 RNA synthesis is constant. A more likely possibility is 
that there is a factor present in the cell at a steady-state concentrati on early 
in the infection which is required for the synthesis of the (+) strand. If such 
factors do exist, YSY replication would be similar to Q(3 replication because the 
QB replicase requires an additional host factor when it is synthesizing the QB 
123 
(-) strand antigenome (8, 13). There is abundant evidence suggesting that 
there are host factors required for the synthesis of 425 RNA ;n vivo (15,25) 
and that these factors interact with one or more of the V5V proteins, most 
likely the L protein subunit of the virion-associated RNA polymerase (14,17, 
19,20,22,23,24) • 
The V5V replicative complex 
The V5V replicative complex was demonstrated to be a ribonucleopro-
tein complex by pulse-labeling V5V-infected cells at the time when V5V 
replication was maximal and analyzing the pulse-labeled cell extracts in Reno-
grafin gradients. The products of replication, (-) and (+) strand RNA destined 
to become 425 RNA, were shown to be ribonucleoprotein complexes by demon-
strating that the nascent RNA was ribonuclease-resistant and single-stranded. 
Preliminary evidence suggests that the N protein associates with the newly 
replicated RNA, thus the finding that the nascent RNPs have the same equilib-
rium densities in Renografin and (sCI as the mature virion nucleocapsids implies 
that the replicative RNP complexes have rhe same ratio of N protein to RNA 
as do the intracellular nucleocapsids. This observation may suggest that the N 
protein plays an integral role in the replication of 425 RNA. Our results also 
show that the repl i cative compl ex of VSV differs from the VSV transcriptive 
complex because transcribing complexes dissociate in Renografin, releasing 
nascent RNA which is cooted with N protein, but forming a ribonuclease-
sensitive structure. 
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The extent of base-pairing befween nascent replicating RNA and tem-
plate RNA is probably minimal. Ribonuclease treatment of the replicative com-
plex after deproteinization indicated that there were no double-strand regions 
in the replicative RNP, even though there must be at least some base-pairing 
at the site where replication is occurring. Several investigators have isolated 
double-strand RNA molecules from VSV-infected cells which have been pro-
posed as possible replicative intermediates (18,26). It is likely that these 
putative replicative intermediates are either artifacts of the phenol extraction 
techniques used to isolate these structures (16) or they are not invol ved in 
rep I i ca ti on • 
Our results suggest that some of the nascent RNP complexes remain 
attached to their templates after isolation in Renografin. If so, it may be pos-
sible to remove the Renografin and complete the nascent strands in vitro. It 
was shown that RNPs obtained from a strain of VSV defective-interfering (DI) 
particles containing a genome which is only 15% of the wild-type genome in 
size are found only in the area of a non-equil ibrium Renografin gradient cor-
responding to the lightest fractions of the trailing edge of Peak I, the replica-
tive RNP complex isolated in Renografin. These same fractions from the trailing 
edge of Peak I contain nascent RNA molecules identical in size to the DI 
particle RNA genome. The peak fractions contain full-length pulse-labeled 
RNA as well as a heterogeneous distributi on of smaller I nascent RNA. It is 
likely that the peak fractions contain nascent RNA attached to templates and 
the trailing fractions contain nascent RNA dissociated from their templates. 
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We cannot excl ude the possibili ty that the trai ling fracti ons of Peak I actualJ y 
contain nascent RNA stj II attached to template RNA, but due to conformati onal 
differences between the RNP complexes in the peak and trailing fractions, the 
RNP complexes in the trailing fractions sediment through the Renografin gra-
dients more slowly than the peak fractions. 
In vi tro 425 RNA synthesis 
The synthesis of 425 RNA was observed in vitro using a V5V-infected 
HeLa cell extract by analyzing the radiolabeled RNA species in methylmercury 
agarose gels; however, this synthesis was not observed using purified virions. 
Our demonstration of 425 RNA synthesis in vitro clearly demonstrates that it 
may be possible to develop an in vitro replication system. It further suggests 
that host or viral factors not present in preparations of purified virions are likely 
to be required for the in vitro synthesis of (+) and (-) 425 RNA. The full-length 
RNA synthesized in vitro was (+) strand RNA and bound to an oligo(dT) column, 
even though the infected cell in vivo produces primarily (-) strand 425 RNA 
whi ch does not bind to an 01 igo(dT) column. This may mean that ,the (+) strand 
425 RNA synthesized in the crude infected cell extract system may not be 
identical to the 425 RNA (+) strands which are found in intracellular nucleo-
capsids (21). Although the synthesis of fuJI-length RNA was not observed using 
purified virions, the synthesis of all of the VSV message species was observed, 
demonstrating that producti on of the VSV mRNAs does not require cell 
extracts (3). 
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Towards a Better Understanding of Y5Y RNA Synthesis 
The studies whi ch are presented herein must be extended before a 
comprehensive understanding of Y5Y RNA synthesis can be obtained. In order 
to leam how the (-) strand RNA viruses regulate transcription and replication, 
the long-term goal of these studies has been the eventual establishment of an 
in vitro replication system capable of synthesizing (+) and (-) strand 425 RNA 
coated with N protein to create a functional template for the in vitro system (4). 
Role of N protein in replicaHon 
It is possible that the N protein must coat nascent RNA if replication 
is to occur. Our studies and the results of others suggest that there are several 
factors that may be required for replication. One or more host factors are likely 
required (15,25) and additional virus factors may also be required for in vivo 
replication. We have demonstrated that the N protein is found associated with 
nascent replicating RNA and perhaps the N protein is one of the viral factors 
necessary for rep Ii cati on. 
It is probable that the same factors required for in vivo replication will 
be required for in vitro replication as well. The crude infected cell extract 
system probably contains all of the host factors involved in V5V replication; 
yet the 425 RNA synthesized in vitro was produced in extremely small amounts 
and the polarity of the in vitro synthesized 42S RNA was only (+). These results 
suggest that there is an additional factor (or factors) required for in vitro repli-
cation that was not present in the infected cell extract system. It is an 
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atrractive hypothesis to propose that the N protein is the missing factor in the 
crude cell extract system. 
The hypothesis that N protein is a required component of replication 
may be incorporated into the processing and stop-start models of repl ication 
cnd transcription described in the first chapter as the means by which transcrip-
tion is switched to replication (1,2). In the processing model, the processing 
endonuclease is prevented from cleaving the (+) strand transcript into the mes-
sage-sized RNA species. The N protein will protect 425 RNA from ribonuclease 
digestion; therefore, the N protein could be the means by which the processing 
endonuclease is inhibited from cutting the transcrip·t. This model of replication 
predicts that the N protein must be added to the nascent RNA soon after the 
initiation of replication has occurred. The leader RNA is identical to the first 
48 nucleotides at the 51 end of the 425 (+) strand and is not found attached to 
the N mRNA (5,6,7). The leader RNA probably serves as the site of the 
initiation of N protein associating with the nascent replicating RNA, if the N 
protein is acting to stabilize the (+) strand 425 RNA transcript. If the function 
of the leader is to initiate the assembly of N protein to the RNA, a leader-
like sequence might also be present at the 51 end of the (-) strand. The ends 
of the genome RNA are not self-complementary; thus if there is an identical 
nucleation site for N protein assembly at the 51 end of the (+) and (-) 425 RNA 
strands, the site is probably only about 8-10 bases long (6,7), although there 
may be separate nucleation sites at the 51 ends of the (+) and (-) strands. 
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The assembly of N protein with the 42S RNA may also be incorporated 
into the stop-start model of replication/ but there is no obvious mechanism by 
which the presence of N protein would prevent the replicase from terminating 
transcription at the end of each gene. The N protein might interact with the 
replicase as the nascent RNA is being coated with protein. Preliminaryevi-
dence indicates that the addition of N protein to 42S RNA will not occur 
spontaneously / suggesting that the N protein must be added to the nascent RNA 
as the RNA is being synthesized. This observation cannot differentiate between 
the stop-start model and the processing model of replication. Perhaps in the 
processing model the replicase also is required to initiate the association of N 
protein with the nascent RNA. It may be possibl e to differentiate between 
these two models by determining if there are processing enzymes present in 
preparations of purified virions capable of cleaving full-length 42S RNA into 
five message-like species. It would be indicative of transcription and replica-
tion occurring by a processing mechanism if deproteinized (+) strand 42S RNA 
could be processed into message-like species in vitro. 
Even if the mechanism by which replication occurs is unknown/ the role 
of N protein in replication may be significant. If N protein must coat nascent 
RNA in order for 42S RNA to be produced/ the effect of adding cycloheximide 
to infected cell s coul d be explai ned. The observati on that VSV transcri pti on 
is unaffected by the addition of cycloheximide to infected cells (27) may imply 
that elongation of nascent 42S RNA is dependent upon the addition of N protein 
or that initiation of replication is somehow linked to the presence of N protein. 
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These two possibilities can be examined by pulse-labeling Y5Y-infected cells 
and analyzi ng the effect of addi ng cycl oheximi de on the si ze distributi on of 
the nascent RNA contained in the replicative complex isolated in Renografin. 
An ini tiati on block woul d resul tin an accumulati on of 425 RNA whereas an 
elongation block would result in a heterogeneous distribution of nascent repli-
cating RNA. But even though the hypothesis that N protein is an integral part 
of replication may be an attractive one( the only way to show that the N pro-
tein is required for replication is to demonstrate a requirement for N protein 
in an in vitro replication system. 
I n vi tro YSY rep Ii cati on 
As we have discussed in the previous section( the possibility that N 
protein may be required for V5Y 425 RNA synthesis cannot be overlooked. It 
will be necessary to ensure that N pro·tein is present in the in vitro system. 
There are two ways that this can be done: N protein can be added to the in 
vitro system or else the replication system can be made a coupled RNA synthe-
sizing-translation system. N protein synthesis has been demonstrate in coupled 
transcripti on-translati on systems (3). 
There are at present two obvious approaches to demonstrating in vitro 
replication. The first involves repeating our observations on the RNA species 
synthesized in the crude infected cell extract system when N protein is present 
in the system. It is preferable to make the crude infected cell extract system a 
coupled system because if the N protein is not the required factor for replica-
tion, it may be possible that the cellular Or viral messcges present in the crude 
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cell extract may be translated to provide the factor and thus allow replication 
to occur. The other approach to establishing an in vitro replication system 
would be to utilize the replicative RNP complex from Renografin. It may be 
possible to complete the synthesis of the nascent strands of the replicative com-
p I ex if the requi red factors are present. These factors will probably inc I ude 
the NS and L proteins, which are lost from the replicative complex after isola-
tion in Renografin, the putative host factors, and the N protein, if it is required 
for the synthesis of 425 RNA. 
I f the crude cell extract system wi II produce detectable amounts of 
(-) strand 425 RNA, or if the replicative complex system will complete the 
nascent RNA strands in vitro, it may be possible to fractionate the systems and 
begin to reconstitute replication activity in the in vitro systems. The partial 
fracti onation of the crude cell extract system has already been performed; how-
ever, the reconsti tuti on of the system's abi I ity to produce 425 RNA was not 
done and such an attempt should now be made. If it is possible to establish an 
in vitro replication system which can be fractionated and reconstituted, replica-
ti on wi II be able to be studied in a simi lar manner to that which Erre rson and her 
coworkers examined transcription (9, 10, 11, 12 ). 
Conclusions 
We have studied the replication of the RNA genome of the rhabdovirus 
vesi cui ar stomati ti s vi rus in order to better understand the means by w hi ch the 
(-) strand viruses regulate their RNA synthesis. These viruses, such as the 
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rhabdoviruses and the paramyxoviruses, contain a virion-associated RNA-
dependent RNA polymerase which appears to be involved in both the replication 
and the transcription of the viral genome. These viruses are unique among 
animal RNA viruses in that replication and transcription are separate functions, 
unlike the other animal viruses which contain (+) strand genomes like polio-
virus. The understanding of the regulation of VSV replication and transcription 
will likely aid in the understanding of the mechanisms by which the host cell 
regulates its own RNA and DNA synthesis. 
The replication of VSV is also important to the study of defective-
interfering particles in that the replication of the DI particle truncated genome 
likely occurs by the same process which is used to replicate the full-length 
genome. If the formation of such particles is due to aberations in replication, 
the study of VSV wild-type replication may aid in the understanding of the 
generation of DI particles. It will be interesting to understand the means by 
which DI particles interfere with the synthesis of the wild-type genome and 
how this affects the ability of certain viruses, such as VSV, to establish 
persistent i nfecti ons. 
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I ntroducti on 
Vesicular stomatitis virus N5V) is a rhabdovirus containing a single 
negative strand of RNA of molecular weight 3.6 - 4.0 x 106 • This RNA con-
tains the genes for the five knO\l\ln virus-specific proteins: G and M, associated 
with the viral lipid envelope; L, Nand N5 which together with the RNA consti-
tute the ribonucleoprotein core of the virus (33). In vitro, low concentrations 
of non-iorlic detergents remove the lipid envelope of VSV and activate the tran-
scriptase enzyme associated with the ribonucleoprotein core to synthesize RNA 
complementary to the V5V genome (6). Early reports of in vitro RNA synthesis 
demonstrated products that were either not characterized or were smaller than 
in vivo messenger RNAs (6,9) . However, many laboratories now demonstrate 
in vitro transcription products which closely resemble the five authentic viral 
messenger RNAs isolated from infected cells: (a) the in vitro mRNA can be 
resolved into four size classes (315, 175, 14.55, 125) by velocity sedimentation 
analysis and by formamide polyacrylamide gels (21,29), and into five size 
classes by duplex formation and polyacrylamide gel electrophoresis of the double 
strands (28 ); (b) they are pol yadenylated, capped and methylated, and they 
hybridize to the genome RNA (21,22,28); (c) they direct the accurate synthesis 
of viral proteins in cell-free systems (10). 
In addition to the five mRNAs synthesized in V5V-infected cells, there 
is also synthesis of genome size (425) RNA. This RNA comprises approximately 
100/0 of the total RNA synthesized (34) and is composed of 425 virion RNA and 
425 RNA complementary to virion RNA, in ratios depending upon the time 
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post-infection (30; Simonsen, et al., manuscript submitted). Progeny 42S RNA 
molecules Cplus ' and 'minus') are essential for virus replication, and 'plus ' 
strand 42S RNA has further been proposed as a precursor to mRNAs (1). How-
ever, the synthesis, in vitro, of 42S RNA is notably absent in most studies. 
Breindr and Holland (11) reported the synthesis of 42S RNA in vitro by purified 
ribonucleoprotein cores under conditions of high sa It concentrati on and after 
the addition of cytoplasmic extract to the reaction, but state that these results 
were not reproducibl e. 
It has been demonstrated that synthesis of virion length RNA in vivo 
requires continuous protein synthesis. I f protei n synthesis is inhibited after the 
onset of RNA replication, further production of 425 RNA ceases (34). Further-
more, many lines of evidence have suggested that host factors may be invol ved 
in the regulation of VSV transcription and replication (24,31). It is thus 
possible that the absence of 42$ RNA from in vitro reactions using highly puri-
fied templates is due to the Joss of crucial host or virus factors during the 
preparati on of these templates. 
In this study, a crude cell extract from V5V-infected cells was used to 
direct RNA synthesis in vitro and the properties of the RNA products of this 
reaction ore compared with those synthesized by purified virions in vitro. 
Materials and Methods 
Cells and media 
HeLa 53 cells were grown in suspension culture in Joklik's modified 
minimal essential medium (MEM) with penicillin and streptomycin (Flow Labs., 
138 
Rockville, Maryland) supplemented with 5% fetal cal f serum. Cells were har-
vested from culture at a density of approximately 5 x 105 cells per mi. 
Grovvth and purification of virus 
He La 53 cells were infected with V5V (Indiana serotype) at 1 pfu per 
cell. After 24 hr at 320 C, cell debris was removed by centrifugation at 700 xg 
for 4 min. The supernatant fraction was recovered, and polyethylene glycol 
(MW 6,000-7,500) and sodium chloride were added to final concentrations of 
79'" and 2.2%, respectively, mixed well and left stirring at 4 0 C for 4-5 hr. 
The precipitated virus was collected by centrifugation at 1,500 x g for 10 min 
at 4 0 C. The pellet was suspended in ET buffer (0.001 M Tris-HCI, pH 7.4, 
0.001 M EDTA) and sonicated for 90 sec. The virus suspension was loaded onto 
a 36-ml linear 10-50010 (w/w) sucrose gradient in ET buffer and centrifuged to 
equilibrium in a Beckman 5W 27 rotor at 23,000 rpm for 17 hr at 4 0 C. The 
visible virus band was collected, diluted with ET and pelleted by centrifugation 
(5W 27 rotor) at 25,000 rpm for 3 hr at 4 0 C. The pellet was suspended in ET 
buffer, sonicated and layered onto a 36-ml linear 30-00/0 (w/w) glycerol -
0-5COIo (w/w) potassium tartrate gradient (25) in ET buffer and centrifuged at 
26,000 rpm for 16 hr at 4 0 C in the 5W 27 rotor. The vi rus band was coil ected . 
and pelleted as above. The pellet was suspended in ET buffer containing 10% 
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Preparati on of infected total cell extract 
Total cell extracts were prepared by a slight modification of Galet et 
8 ~ (1973). 1-2 x 10 HeLa cells were collected by centrifugation, resuspended 
to 1-2 x 10
7 
cells per ml in MEM, infected with VSV at 10 pfu per cell, and 
incubated at 370 C. A~ 1 hr post-infection, Actinomycin D (Merck & Co., 
Inc., New Jersey) was added to 5 iJg per mt, and at 1 .5 hr, fetal calf serum 
was added to 5%. After 4-5 hr of incubation, cells were collected by centri-
fugation at 700 x 9 for 4 min, and washed once by resuspension and centrifuga-
tion in cold Earle's salt solution. The washed cell pellet was resuspended in 
1 ml of cold Tris-HCI buffer (0.05 M, pH B.O) and disrupted with 25 strokes of 
a Dounce homogenizer. This extract was used immediately for in vi tro RNA 
synthesis. 
Fractionation of cell extract 
The total cell extract described above was centrifuged at 700 x 9 for 
4 min to remove the nuclei. The supernatant (llnu clear supernatant") was cen-
trifuged at 16,000 x 9 for 10 min to remove mitochondria and large organeJ les. 
The supernatant ("mitochondrial supernatant") was centrifuged in a Beckman 
angle 65 rotor for 2 hr at 35,000 rpm at 4 0 C. The pellet was resuspended in 
0.01 M Tris, pH 8.0; 0.002 M DTT; 10% glycrol. This is referred to as the 
1/ crude cores II fracti on. 
In vitro RNA synthesis 
RNA was synthesized in vitro in a 0.2-ml reaction mix containing 
0.05 M Tris-HCI (PH 8.0); 0.1 M NaC) (0.05 M for cell extracts)i 0.005 M 
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MgCI2; 0.005 M dithiothreitor; 0.005 M spermidine (Sigma, St. louis, MO); 
0.0005 M S-adenosyr-l-methionine chloride (Sigma);5 jJg rat liver ribonuclease 
inhibitor (prepared according to Gribnau et 01., 1969); 0.05% Triton N10l 
(omit for cell extract); 0.001 M ATP, CTP and GTP (sodium salts, Sigma); 
0.0001 M UTP and 40 jJCi [5-3H]-UTP (specific activity approximately 20 Ci 
per mmole, New England Nuclear, Boxton, Mass.). Approximately 45 jJg pro-
tein (determined by the method of lowry et al. t 1951) of purified VSV, 1-"/.25 
mg protein of cell extract, or 550 jJg protein of IIcrude cores II were used for each 
0.2-ml reaction. Incubation was at 300 C for 2 hr unless otherwise indicated. 
Samples containing total cell extract were centrifuged at 700 x 9 for 4 min at 
4 0 C to remove the nuclei. The nuclear pellet was washed with 0.2 ml RSB 
buffer (0.01 M Tris-HCI, pH 7.4; 0.01 M NaCI; 0.0015 M MgC'2) containing 
1 % NP-40 (Shell Oil Co.) / and recentri fuged. The combi ned supernatants 
were added to 2.6 ml TNE buffer (0.01 M Tris-HCI, pH 8.3; O. 15 M NaCI; 
0.005 M EDTA) containing 1% sodium dodecyl sulphate (SDS), and phenol 
extracted as described below. Sampl es contai ning vi ri ons or cores were added 
directly to TNE/SDS buffer. 
In vivo RNA synthesis 
Approximately 5 x 106 Hela cells, infected with VSV as previously 
described, were incubated with 100 !lCi [5 t 6-3H]-uridine per ml (specific 
activity 47.5 Ci per m mole, New England Nucleart Boston t Mass.) for 15 min 
at 370 C. Cells were collected and washed as previously described. The 
pelleted cells were resuspended in 0.5 ml RSB buffer and lysed by the addition 
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of NP-40 to 10/0. Nuclei were removed by centrifugation at 700 x g for 4 min, 
and the crude cytoplasm was analyzed for RNA species. 
Analysis of RNA products 
(a) In vitro incorporation of 3H- UTP 
Duplicate 10 ~I samples of the in vitro reaction mix were precipi-
tated with 10910 trichloroacetic acid (TCA), containing 0.05 M sodium pyro-
phosphate and 0.05 M sodium phosphate and collected by filtration on GF/C 
fil ters (Whatman Ltd., England). The fi I ters were washed, dried and assayed 
in toluene based scintillation fluid. 
(b) Phenol extracti on of RNA 
An equal volume of TNE-saturated phenol was added to the sam-
ples in TNE-SDS buffer, mixed and the two layers separated by centrifugati on. 
The aqueous layer was collected and the phenol Jayer was extracted once more 
with 3 ml of TNE containing 10/0 50S. The aqueous fractions were combined, 
sodium acetate added to a final salt concentration of 0.2 M, two volumes of 
ethanol added, and the RNA prec ipi tated at _700 C overnight. RNA was 
pelleted by centrifugation at 16,000 x g for 30 min at 4 0 C. 
(c) Oligo (dT)-celiulose chromatography of RNA 
Oligo {dT)-cellulose (Collaborative Research, Inc. Waltham, 
Mass.) columns were prepared and eluted according to Banerjee and Rhodes (7). 
The high salt-elution buffer contained 0.01 M Tris-HCI, pH 7.4; 0.5 M NaCI; 
and the low salt buffer contained 0.01 M Tris-HC! I pH 7.4. RNA was phenol 
extracted and ethanol precipi tated as described above and loaded onto the 
column in high salt buffer. Bound and unbound material was pooled and 
ethanol-precipi tated as described above. 
(d) Methylmercury-agarose gel electrophoresis 
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Methylmercury-agarose gel electrophoresis was performed accord-
ing to a modification of Bailey and Davidson (3). Seakem agarose powder was 
obtained from Marine Colloids, Inc. and methylmercury (11) hydroxide was 
obtained as a 1 M solution from Alfa Products, Danvers, Mass. Because of the 
toxic and volatile nature of the mercury compound, operations were performed 
under a hood. Horizontal slab gels (19 cm x 13 .. 3 cm x 0.4 cm; 100 ml bed 
volume) were 1% agarose in borate buffer (0.05 M boric acid, 0.005 M sodium 
borate, 0.01 M sodium sulphate and 0.001 M trisodium EDTA, pH 8.0), and 
contained 0.005 M methylmercury hydroxide. Samples were appli ed in 40 ~( 
of 1 : i, sample :sample buffer (borate buffer containing 5001c glycerol, O.l~{, 
bromophenol blue) with methylmercury hydroxide added to a concentration of 
0.005 M iust prior to loading onto the gel. The gel reservoirs contained borate 
buffer I and this buffer was recirculated at approximatel y 80 ml per hr through-
out the electrophoresis period. Gels were run at 75-100 V (50 rnA) for 6 hr 
(dye front migrated 14 cm). 
(e) Fluorography of methylmercury gels 
Gels containing 3H- RNA were fixed for 10 min in Too/c acetic 
acid containing 0.01 M cysteine. They were dehydrated in 10{)o/c methanol for 
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two successive 1-hr periods. After drying down to paper thinness under vacuum, 
the gels were soaked in a 100le (w/v) solution of 2,5-diphenyfoxazole (PPO, 
New England Nuclear, Boston, Mass.) in methanol for 3 hr. Gels were soaked 
in water for 10 mi n to precipi tate the PPO I blotted dry and mounted on a pi ece 
of 3 MM paper (Whatman, Ltd., Eng land) . After coveri ng wi th 5aran Wrap, 
o gels were exposed to Kodak X-ray 5B-5 film at -70 C and developed after 
appropriate peri ods of 1"ime . 
Resul ts 
Comparison of RNA · .... ~hp.<;ized in V5V-infected cells with RNA synthesized 
in vitro by infected cell extracts 
It has been demonstrated previously that the mRNA species synthesized 
in vitro by purified virions of VSV foil into 4 size classes - 315, 175, 14.55, 
and 125 (21,29). A small RNA, termed uleader ll RNA, is also a product of in 
vitro synthesis (12). 
In VSV-infected cells, however, genome length 425 RNA is synthesized 
in addition to mRNA species. At 4 hr post-infection, this RNA has been shown 
to be composed of single stranded 425 virion RNA and 425 RNA complementary 
to virion RNA in a tatio of 4: 1 (30; 5imonsen et al., manuscript submitted). 
Figure 1 shows methylmercury-agarose gel analysis of the RNA synthesized in 
v 5 V-infected cells as a function of time post-infection. The major RNA 
species are 425, 315, 175, 14.55 and 125, with maximum amounts of 425 
RNA being synthesized between 3 and 5 hr post-i nfecti on. In considerati on of 
the possibility that 425 RNA synthesis might require both viral and/or host cell 
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Fig 1. Ana lysis of RNA products synthesized in V5V-infected cells as a func-
tion of time pest-infection. Hela cells were infected with V5V, labeled with 
[5,6-3H]-uridine and the cytoplasmic RNA prepared as described. The RNA 
was phenol extracted, ethanol precipitated and electrophoresed on a methyl-
me rcury-agarose gel. The gel was fJ uorographed as described, and exposed to 
X-ray film for 4 days. 425 and 315 RNA markers (A)i 12-175 mRNA markers 
(B); 2 hr post-infection, 27,000 rpm (C)i 3 hr post-infection 31,000 cpm (0); 
4 hr post-i nfecti on, 29,000 cpm (E)i 5 hr post-i nfecti on, 32,000 cpm (F)i 6 hr 
post-i nfecti on, 19, 000 cpm (G); 7 hr post-i nfecti on, 9/000 cpm (H). 
425-
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factor(s}, total unfractionated cell extracts were prepared from VSV-infected 
HeLo cells at different times after infection and assayed for RNA synthesis in 
vitro. These extracts showed good RNA synthesis activity and the incorporation 
~ 
of ..... H-UTP increased linearly up to 7 hr post-infection as shown in Figure 2. 
315 and 12-175 mRNAs are made in significant amounts by extracts prepared ot 
all times post-infection. The synthesis of 425 RNA in vitro is clearly evident 
in extracts pr.epared from 3-6 hr post-infection as shown in Figure 3. The 425 
RNA represents only 1-2% of the tota', but it is a consistent and reproducibl e 
product. It also appears that maximum in vitro 425 RNA synthesis by cell 
extracts occurs at the same time post-infecti on as when maximum 425 RNA 
synthesis is occurring in the cell. 
Comparison of in vitro RNA synthesis by purified virions and by infected cell 
extracts 
Many previ ous reports have examined in vitro RNA synthesis by purified 
virions or by purified ribonucleoprotein particles (11,21,27). These studies 
have demonstrated varying success in producing RNAs of the same size as those 
observed in vivo and one report of 425 RNA synthesis is inconclusive (11). We 
therefore compared the products of RNA synthesis by crude, infected cel( ex-
tracts with those synthesized by purified virions. Figure 4 shows that incorpora-
tion of [3HJ-UTP into TeA insoluble material in a virion-primed in vitro assay is 
linear for 2 hr and, depending upon the virus preparation, continues at the same 
or slightly reduced rate for more than 8 hr (data not shown). In a cell extract-
primed reaction, incorporation occurs at a linear rate until approximately 90 
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Fig 2. In vitro RNA synthesis by VSV-infected cell extracts as a function of 
time post-infection. Approximately 1 x 108 VSV-infected cells were used to 
prepare 1 ml of total extract at 2, 3, 4, 5, 6 and 7 hr post-infection. Extracts 
were incubated in the in vitro transcription reaction for 2 hr. Duplicate samples 
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Fig 3. Analysis of RNA species synthesized in vitro by V5V-infected cell 
extracts as a function of time post-infection. RNA was prepared from the 
reacti ons described in Figure 2 and electrophoresed in methyl mercury-
agarose gels. Gels were fluorographed as described, and exposed to X-ray 
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film for 14 days. V5V marker RNAs (A, B)i extracts prepared 2 hr (C), 3 hr 
(D),4 hr (E), 5 hr (FL 6 hr (G), and 7 hr (H) post-infection. The autoradiogram 
is overexposed in 12-175 RNA region in order to show 425 RNA band. 











Fig 4. Kinetics of incorporation of [3H]-UTP directed by infected extract, 
uninfected extract and by vi ri ons. Transcriptase reacti ~ns were performed as 
described. Duplicate samples were analyzed for TCA precipitable radioactivity 
at the indicated times. ea__--ae infected cell extract; .6:r---,L1virionj 
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min (Figure 4) and con'finues at a reduced rate thereafter. The products of 
these reacti ons during the I inear phase up to 2 hr can be seen in Figure 5. The 
cell extract synthesizes detectable amounts of 425 RNA and 315 mRNAr and 
significant amounts of 12-175 mRNA after 30 r 60, 90 and 120 min of incorpora-
ti on. All of these products are seen even after 8 hr of i ncorporati on (data not 
shovvn) indicating that little degradation occurs in vitro. Additional RNA bands 
which do not correspond to genome-sized 425 RNA or YSV mRNA species can 
also be observed at approximately 11365" r 112651/ r and "45 11 as well as less 
distinct bands betvveen 315 and 175 and less than 125. A number of these minor 
bands are also seen amongst the RNAs extracted from Y5Y-infected cells as seen 
in Figure 1. These RNA products have not been previously identified r since 
they probably would not have been resolved by previous methods of analysis. 
The RNA products from a virion-primed in vitro assay are also shown 
in Figure 5 for comparison with the products synthesized by cell extracts. No 
detectable 425 RNA is synthesized by purified virions, but distinct mRNA bands 
(315, 175 r 14.55 r 125) are seen as virion products in vitro. In addition r there 
are signi fj cant amounts of "365 II from 1-2 hr r a band at approximatel y 11205 II 
and a band migrating faster than 45 r which is possibly the leader RNA pre-
viously described (12). Although diffuse bands of RNA between 175 and 315 
are produced in the virion reaction r the distinct 11265" band seen in the extract 
reaction is not apparent. The RNA species synthesized in vitro by virions are 
also seen after 8 hr of incorporati on of [3H]-UTP (data not shown). 
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Fig 5. Products of in vi tro RNA synthesis as a functi on of time of reacti on. 
An infected cell extract was prepared as described, and both extract and vi ri on 
directed in vitro RNA products from 200 jJl of assay mix were analyzed after 30, 
30, 90 and 120 min of synthesis by methylmercury-agarose gel electrophoresis. 
Approximately 60,000 TeA insoluble cpm were used for each sample and 
exposure time was 12 days. In vivo 425, 315 and 12-175 RNAs (A)i RNA 
synthesized by extract after 30 min (B); 60 min (D); 90 min (F)i and 120 min (H) 
of reaction: RNA synthesized by virions after 30 min (C), 60 min (E), 90 min 
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The effects of different reaction conditions on in vitro synthesis of RNA by 
purified virions and by cell extracts 
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It can be see in Figure 1 and 3 that relative to mRNA, considerably 
mOre 425 RNA is synthesized in VSY-infected cells then is synthesized in vitro 
by total cell extracts. Attempts were thus made to vary the in vitro reaction 
conditions to optimize 425 RNA synthesis. The following parameters were 
varied: Triton N101 (0-5%); NaCI (0-0.5 M)i MgCI2 (0-0.05 M); ATP, CTP, 
GTP, UTP (0-0.004 M); pH (6.3-8.5); NaCI replaced by KCI (0.05 M and 
0.1 M); rat liver RNase inhibitor (0-12.5 t'g); S-adenosyl-L-methionine 
chloride (0 or 0.0005 M); concentration of cell extract (0-1.6 mg protein); 
and the effect of selective protease inhibitors (phenylmethylsulfonylfluoride, 
PMSFi L-l-tosylarnide-2-phenyl ethyl chi oromethyl ketone, TPCK; and N-a-
p-tosyl-L-Iysine-chloromethylketone, TLCK (Sigma)) present either in the in 
vitro RNA synthesis reaction, the preparation of the cell extract, or both. 
None of these attempts resulted in any significant increase in the synthesis of 
425 RNA as visualized from methylmercury gels. Although other workers have 
reported that certain conditions l e.g., high salt (11) or addition of cytoplasmic 
extract (4 / 5,11), are necessary for stimulated RNA synthesis and intact product, 
this has nor been observed in our laboratory. The conditions for in vitro RNA 
synthesis described in the Experimental Procedures represent optimal [3H]-UTP 
i ncorporati on condi ti ons . 
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Analysis of RNA products by oligo (dT)-cellulose chromatography 
In vitro RNA products from virion and extract reactions were further 
characterized for the presence of poly (A) sequences by chromatography on 
oligo (dT)-cellulose. RNAs were adsorbed to and eluted from the column as 
described in the Experimental Procedures and bound and unbound RNAs were 
collected and ethanol precipitated. These classes of RNA were analyzed on a 
methylmercury gel and the results are shown in Figure 6a. Polyadenylated 
virion product RNA includes all V5V mRNA species (315, 175, 14.55 and 125) 
and the uncharacterized "365 11 and 11205 11 species. Virion product RNA which 
dtd not bind to the column consists of RNA species slightly smaller than "205", 
175, 14.55 and 125. These may represent non-polyadenylated mRNAs and/or 
incomplete, nascent RI'IA molecules. The small (less than 45) RNA species 
appears to lack poly (A) sequences. 
Polyadenylated RNA synthesized in vi tro by an infected cell extract 
contained the majority of the 425 RNA, the "365" RNA and all of the mRNA 
species (315, 175, 14.5$, 12$). Figure 6b shows densitometer traces of the 
top portion of the autoradiogram and these further confirm that the in vitro 425 
RNA binds to oligo (dT)-cellulose. 
RNA which did not bind to the cdumn consists of a trace of the 42$ 
RNA, the "265 11 RNA, material which comigrates with the mRNA species and 
the material which is less than 12$. 
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Fig 6. a. Oligo (dT)-cellulose chromatography of RNA products from infected 
cell extract and viri on directed synthesis. After 2 hr of vi ri on and ceJ I extract-
directed in vitro synthesis, RNA was prepared for electrophoresis and for oligo 
(dT)-cellulose chromatography. Bound and unbound material from the 01 igo 
(dT) column was pooled, ethanol precipitated and electrophoresed on methyl-
mercury-agarose gels. Approximately 15, 000 TCA insoluble cpm were used for 
each sample, and gel exposure time was 35 days. Viri on products, total (A); 
virion products, bound (B); virion products, unbound (C); extract products, 
tote I (D); extract products, bound (E)i extract products, unbound (F). 
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RNA synthesized in vitro by fractionated cell extracts 
It has been demonstrated in Figure 3 that when an infected cell extract 
synthesizes RNA in vi tro, a 425 RNA product is observed. However, this has 
never been demonstrated with a highly purified system using either purified 
virions or ribonucleoprotein particles. The cell extract was/ therefore/ frac-
tionated by differential centrifugation to determine whether the capacity to 
synthesize 425 RNA was lost during purification of viral cores. 
Infected-cell extracts were fractionated as described in the Experimen-
tal Procedures. At iquots of total cell extract/ "nuclear supernatant", "mito-
chondrial supernatant ll and "crude cores" were assayed for in vitro RNA synthe-
sis. Table 1 shows that the in vitro RNA synthesizing activity by each fraction 
is completely recovered. No RNA synthesis has been detected in the final 
supernatant (data not shown). The RNA speci es produced were analyzed by 
methyfmercury-agarose gel electrophoresis and densitometer traces of the top 
portion of the autoradiogram as shown in Figure 7. Appreciable 425 RNA is 
synthesized by the total cell extract/ I1nuclear supernatant" and IImitochondrial 
supernatant", but to a negligible extent by the IIcrude cores". 
The effect of cycloheximide treatment of cells on in vitro RNA synthesis by 
cell extracts. 
It is known that cycloheximide treatment of V5V-infected cells results 
in complete inhibition of replication, with transcription remaining unaffected 
(34). We, therefore / prepared extracts from infected cells wh i ch had been 
162 
TABLE 1 
RECOVERY OF IN VITRO RNA SYNTHESIS IN FRACTIONATED, 
INFECTED CELL EXTRACTSa 
Fraction 
Total extract 
II Nuclear supernatant ll 
IIMitochondrial supernatant ll 
IICrude cores ll 





0/0 Rec overy 
93% 
960/0 
a Infected cell extracts were fracti ana ted and assayed for in vitro RNA synthesis 
as described. Duplicate samples were taken after 2 hr of synthesis and analyzed 
for TCA insoluble radioactivity. 
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Fig 7. Synthesis of 42S RNA in vitro by fractionated infected cell extracts. 
An infected cell extract was prepared, fractionated and analyzed for RNA 
synthesis in vitro. After 2 hr of synthesis, the RNA was prepared and electro-
phoresed on methylmercury-agarose gels. The top porti on of the autoradiogram 
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treated with cycloheximIde, and tested their ability to synthesize 425 RNA 
in vi tro. 
HeLa cells were infected with V5V and at 4 hr post-infection an 01 iquot 
of infected cells was treated with cycloheximide at 100 ~g per ml for 30 min. 
Extracts were then prepared from both cycloheximide treated and untreated 
cells, and assayed for in vitro RNA synthesis. Cyel oheximi de treatment of 
cells either stimulated or had no effect upon 3 H- UTP incorporati on in vi tro, 
depending upon the extract preparation (data not shown). Densitometer traces 
of the autoradi ogram shown in Figure 8 demonstrate that, whereas the untreated 
cell extract synthesizes 425 RNA, the cycl oheximi de treated extract shows no 
evidence of 42$ RNA synthesis. 
Di scussi on 
V5V-·jnfected cells synthesize progeny 42$ RNA plus the messenger 
RNAs which code for the five viral proteins (34; Figure 1). However, studies 
of in vitro RNA synthesis by purified virions or nucleocapsids have failed to 
consistently demonstrate the synthesis of any full-length vi ral RNA (5,21). 
In this study total cell extracts from V5V-infected cells were shown 
to synthesize full-length viral RNA in vitro. The use of similar extracts for in 
vitro RN.A synthesis has been reported previously (15,16,17,23,35), but the 
RNA products of these reactions were shown to sediment only in the 4-185 
iegi ons of a sucrose gradient (15), and other investigators often chose to purify 
the intracellular ribonucleoprotein cores for their more detailed analyses (16, 
23,32) . 
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Fig 8. 425 RNA synthesis in vitro by extracts prepared from untreated and 
cycl oheximide treated cells. After 2 hr of synthesis, RNA was prepared and 
analyzed by methylmercury-agarose gel electrophoresis. The top portion of 























The involvement of host cell factors in VSV replication and transcription 
has been suggested in previ ous studies. For example, host range mutants have 
been reported which are defective in RNA replication in the non-peimissive 
cell (31), and in some cell lines, wild-type V5V replication is specifically 
blocked (24). The system reported in this study utilizes whole cell extracts 
or fractions thereof which are likely to contain essential host cell factors which 
are not apt to be present in in vitro RNA synthesis reactions which utilize 
purified virions or ribonucleoprotein cores. When ribonucleoprotein cores 
were prepared from the extract, 425 RNA synthesis was neg I igibl e, aro when 
purified virions were used to direct RNA synthesis, no 42S RNA was detectable. 
These results strongly suggest the involvement of cellular or viral factors in the 
synthesis of 425 RNA in vitro and indicate that these factors may be lost or 
inactivated in subsequent purifications of cores or virions. Since 42$ RNA 
synthesis is observed in the crude system, and this activity is lost after purifico-
Hon steps, it is possible that reconstitution experiments could restore 42S RNA 
synthesis, and this work is in progress. 
The nature and frunction of the 42S RNA synthesized in vitro has not 
been fully characterized. However I' some properties have been observed. 
Firstly, the maiority of the 42$ RNA binds to an oligo (dT)-cellulose column. 
Previous analyses of RNA extracted from purified viri ons has demonstrated no 
adenylate-rich sequences (14). Morrison et al. (20) showed that a fraction of 
intracellular 425 RNA bound to poly-U filters. Since (-) 425 RNA would not 
be expected to bind, they concluded that (+) 425 RNA is polyadenylated, 
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although the bound material was not identified. Preliminary hybridization 
experiments (data not shown) have been performed with the in vitro synthesized 
42S RNA isolated from methylmercury-agarose gels and the resul ts suggest that 
the maiority of the in vitro 42S RNA is (+) strand. This is in contrast to the 
in vivo situation where 80% of the intracellular 425 RNA is (-) strand. 
Secondly I synthesis of 42S RNA disappears when extracts are prepared 
from cells pre-treated with cycloheximide. In vitro viral transcriptase activity 
in infected extracts of Chinese hamster ovary cells was inhibited by 95% if 
these cells were pre-treated with cycloheximide (Murphy and Lazzarini, 1974). 
This is in contrast to our results, where cycloheximide had no inhibitory effect 
on total RNA synthesis. The mechanism by which the V5V genome RNA is 
replicated and the nature of the RNA of replicative intermediates remain 
largely unknown. Progeny 425 (+) and (-) molecules are obviously integral to 
this process. It has been demonstrated that in vivo synthesis of progeny virion 
length RNA requires continuous protein synthesis, since 425 RNA production 
was 95% inhibited when cells were treated with cycloheximide (26,34). More-
over, some authors (1) have proposed that a (+) 42S RNA serves as a precursor 
to mRNAs as well as an intermediate in virus replication. Messenger RNA syn-
thesis should be unaffected by cycloheximide treatment while re,jlication is 
completely inhibited. Extracts of cycloheximide-treated cells were examined 
for their ability to synthesize 425 RNA in vitro in an effort to determine whether 
this product represented an intermediate in messenger RNA synthesis or was the 
result of virus replication events. The specific loss of 425 RNA synthesis by the 
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cycloheximide-treated extracts (Figure 8) suggests that this RNA is a product 
of viral replication. 
The 425 RNA synthesized in vivo represents approximately 8-10~1o of the 
total RNA, whereas in vitro it is only 1-2% of the total. The reason for this 
quantitative discrepancy is unknown. It is possible that no (-) strand RNA is 
synthesized in vitro, and 425 RNA which is synthesized represents only the 
genome-length (+) strand RNA, made in similar amounts in vivo. It is also pos-
sible that the in vitro synthesis of 425 RNA derives from premade templates 
(which are 80010 (-) strand) in the cell extract and that the reaction in vitro is 
very inefficient. It is not known at this time whether the in vitro 425 RNA 
results from de novo synthesis, or frcm completion of nascent molecules which 
are initiated in vivo. Initial attempts to determine the extent of in vitro synthe-
sis of the 425 RNA molecules using brominated-UTP and density shift centrifu-
gati on were unsuccessful due to the absence of i ncorporati on of the brominated-
UTP into RNA. However, if the in vitro 425 RNA molecules merely represented 
completed chains, they would be expected to be primari Iy (-) strand. 
In vitro RNA synthesis by purified viri ons is also described in this paper, 
and we found that synthesis continued for long periods of time (linear for 8 hr 
in some reaction) and produced full-sized transcripts at all times. Ball and 
White (5) reported that the addition of cytoplasmic extracts to their in vitro 
reacti ons produced a simi lar result I but we have found this to be unnecessary 
for optimal in vitro transcription. The use of rat liver ribonuclease inhibitor to 
increase both the synthesis and the messenger activity of the RNA produced in 
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vitro has also been previously reported (27). This inhibitor was used in our 
study, since preliminary results indicated a similar stimulation of RNA synthesis 
and production of full-sized RN,L\s (data not shown). 
The RNAs produced by virion directed in vitro synthesis represent intact 
V5V messenger RNAs - 315, 175, 14.55, and 125; no 425 RNA was synthesized 
in vitro by virions. An RNA species which was smaller than 45 RNA was also 
synthesized, and this RNA resembles the IIleader ll RNA described by Colonno 
and Banerjee (12) in the following properties: (1) it is the appropriate size (less 
thatn 45), since the "leader ll is reported to be 48 nucleotides in length (13); 
(2) it is not polyadenylated (12); (3) it disappears when an uninfected cytoplas-
mic extract is added to a virion-primed reaction (data not shown) which may be 
due to a 51 exonuclease activity in the extracts (Banerjee, personal communica-
tion). The complete nucleotide sequence of the leader RNA has naw been 
established (13)/ and further conclusions on the nature of our small RNA species 
must await a more rigorous analysis. 
Oligo (dT)-cellulose chromatography of the virion directed in vitro RNA 
products demonstrated that the polyadenylated RNAs represent the RNA species 
previously characterized as V5V messenger RNAs. The unbound material, how-
ever, contained RNA molecules which migrated slightly fas ter than their bound 
counterparts., a phenomenon which has been observed previously by others (5, 
22). Moyer et al. (22) suggested that the faster migrating species of unbound 
RNAs might reflect the lack of poly (A) sequences and/or the presence of 
incomplete molecules. However, Rose et al. (29) showed that when the poly 
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(A) tracts were enzymatically removed from mRNAs they stifl co-migrated on 
formamide polyacrylamide gels with the polyadenylated mRNAs. Ball and 
White (5) demonstrated that the R~-.JA species lacking poly (A) were synthesized 
de novo, and that this synthesis increased at later times of the in vitro reaction. 
They suggested that a selective inactivation of the viral poly (A) polymerase 
was responsible for this. 
In addition to the known V5V RNA species (425, 315, 175, 14.55, 
12S) I this study demonstrates that many other RNA speci es are synthesized both 
in vitro and in vivo. The detection of these RNAs in this study is due to the 
high resolution possible with the methylmercury-agarose gels. The function 
and origin of these RNAs is under study at the present time. 
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